<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title>Other disease</title>
  <style type="text/css">
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    span.underline{text-decoration: underline;}
    div.column{display: inline-block; vertical-align: top; width: 50%;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
  </style>
  <script src="OtherDiseases_auto_files/header-attrs-2.8/header-attrs.js"></script>
</head>
<body>
<div id="header">
<h1 class="title">Other disease</h1>
</div>
<style type="text/css">

body{
    background:#F0F0F0;}
blockquote{
  text-align: center;
  font-size: 18px;}

</style>
<p><em>[auto-generated file]</em></p>
<p>Other disease is a <strong>death cause</strong>. It means that there is a certain probability that one dies from this.</p>
<div id="alternative-names" class="section level4">
<h4>Alternative names:</h4>
<ul>
<li>Other dis.</li>
<li>Other disease</li>
<li>OtherDiseases</li>
</ul>
</div>
<div id="categories" class="section level4">
<h4>Categories</h4>
<p>Other disease is part of the following death cause categories</p>
<ul>
<li><a href="/model/NonViolentDeath">Non-violent death</a></li>
</ul>
</div>
<div id="risk-factors" class="section level4">
<h4>Risk factors</h4>
<p>Other disease has no <a href="/model/intro#risk-factor">risk factors</a> in the model (yet).</p>
</div>
<div id="number-of-deaths" class="section level4">
<h4>Number of deaths</h4>
<p>In 2014 Other disease was responsible for 12.9% of the deaths in the US. Below is a plot of how prevalent the death was for different ages <span class="citation">(Xu et al. <a href="#ref-CDCreport" role="doc-biblioref">2016</a>)</span></p>
<p><img src="OtherDiseases_auto_files/figure-html/unnamed-chunk-2-1.png" width="672" /></p>
</div>
<div id="definition" class="section level4">
<h4>Definition</h4>
<p>The definition of dying from Other disease is to get any of the following ICD codes as the main cause of death on one’s death certificate. The percentage is the proportion of the deaths from Other disease who falls under the ICD code</p>
<ul>
<li><details>
<summary>
F (44.6%)
</summary>
<ul>
<li><strong>F0 (40.8%)</strong>
<ul>
<li>F01: Vascular dementia (4.3%)
<ul>
<li>F010 (0.0003%)</li>
<li>F011 (0.39%)</li>
<li>F013 (0.0003%)</li>
<li>F018 (0.0015%)</li>
<li><strong>F019 (3.9%)</strong></li>
</ul></li>
<li><strong>F03: Unspecified dementia (36%)</strong></li>
<li>F05: Delirium due to known physiological condition (0.28%)
<ul>
<li>F051 (0.13%)</li>
<li>F059 (0.15%)</li>
</ul></li>
<li>F06: Other mental disorders due to known physiological condition (0.17%)
<ul>
<li>F067 (0.0041%)</li>
<li>F068: Other specified mental disorders due to known physiological condition (0.0003%)</li>
<li>F069 (0.17%)</li>
</ul></li>
<li>F07: Personality and behavioral disorders due to known physiological condition (0.003%)
<ul>
<li>F070: Personality change due to known physiological condition (0.0012%)</li>
<li>F071 (0.0003%)</li>
<li>F072 (0.0015%)</li>
</ul></li>
<li>F09: Unspecified mental disorder due to known physiological condition (0.00089%)</li>
</ul></li>
<li>F1 (3.1%)
<ul>
<li><strong>F10: Alcohol related disorders (2.3%)</strong>
<ul>
<li>F101: Alcohol abuse (0.81%)</li>
<li><strong>F102: Alcohol dependence (1.3%)</strong></li>
<li>F103 (0.053%)</li>
<li>F104 (0.021%)</li>
<li>F105 (0.00059%)</li>
<li>F106 (0.0074%)</li>
<li>F107 (0.073%)</li>
<li>F109: Alcohol use, unspecified (0.066%)</li>
</ul></li>
<li>F11: Opioid related disorders (0.078%)
<ul>
<li>F111: Opioid abuse (0.041%)</li>
<li>F112: Opioid dependence (0.0065%)</li>
<li>F113 (0.0015%)</li>
<li>F117 (0.00059%)</li>
<li>F119: Opioid use, unspecified (0.028%)</li>
</ul></li>
<li>F12: Cannabis related disorders (0.0024%)
<ul>
<li>F121: Cannabis abuse (0.0003%)</li>
<li>F129: Cannabis use, unspecified (0.0021%)</li>
</ul></li>
<li>F13: Sedative, hypnotic, or anxiolytic related disorders (0.003%)
<ul>
<li>F131: Sedative, hypnotic or anxiolytic-related abuse (0.00059%)</li>
<li>F132: Sedative, hypnotic or anxiolytic-related dependence (0.0003%)</li>
<li>F133 (0.00059%)</li>
<li>F137 (0.0003%)</li>
<li>F139: Sedative, hypnotic or anxiolytic-related use, unspecified (0.0012%)</li>
</ul></li>
<li>F14: Cocaine related disorders (0.073%)
<ul>
<li>F141: Cocaine abuse (0.038%)</li>
<li>F142: Cocaine dependence (0.0003%)</li>
<li>F149: Cocaine use, unspecified (0.035%)</li>
</ul></li>
<li>F15: Other stimulant related disorders (0.058%)
<ul>
<li>F151: Other stimulant abuse (0.037%)</li>
<li>F152: Other stimulant dependence (0.00089%)</li>
<li>F159: Other stimulant use, unspecified (0.021%)</li>
</ul></li>
<li>F17: Nicotine dependence (0.12%)
<ul>
<li>F171 (0.0083%)</li>
<li>F172: Nicotine dependence (0.00089%)</li>
<li>F179 (0.11%)</li>
</ul></li>
<li>F18: Inhalant related disorders (0.0065%)
<ul>
<li>F181: Inhalant abuse (0.0065%)</li>
</ul></li>
<li>F19: Other psychoactive substance related disorders (0.45%)
<ul>
<li>F191: Other psychoactive substance abuse (0.36%)</li>
<li>F192: Other psychoactive substance dependence (0.014%)</li>
<li>F193 (0.0041%)</li>
<li>F195 (0.0003%)</li>
<li>F197 (0.003%)</li>
<li>F199: Other psychoactive substance use, unspecified (0.06%)</li>
</ul></li>
</ul></li>
<li>F2 (0.16%)
<ul>
<li>F20: Schizophrenia (0.13%)
<ul>
<li>F200: Paranoid schizophrenia (0.014%)</li>
<li>F201: Disorganized schizophrenia (0.0003%)</li>
<li>F202: Catatonic schizophrenia (0.0059%)</li>
<li>F203: Undifferentiated schizophrenia (0.00089%)</li>
<li>F204 (0.00059%)</li>
<li>F205: Residual schizophrenia (0.012%)</li>
<li>F209: Schizophrenia, unspecified (0.093%)</li>
</ul></li>
<li>F21: Schizotypal disorder (0.0003%)</li>
<li>F22: Delusional disorders (0.0021%)
<ul>
<li>F220 (0.0021%)</li>
</ul></li>
<li>F23: Brief psychotic disorder (0.0024%)
<ul>
<li>F239 (0.0024%)</li>
</ul></li>
<li>F25: Schizoaffective disorders (0.013%)
<ul>
<li>F252 (0.0003%)</li>
<li>F259: Schizoaffective disorder, unspecified (0.013%)</li>
</ul></li>
<li>F29: Unspecified psychosis not due to a substance or known physiological condition (0.012%)</li>
</ul></li>
<li>F3 (0.19%)
<ul>
<li>F30: Manic episode (0.00089%)
<ul>
<li>F308: Other manic episodes (0.00089%)</li>
</ul></li>
<li>F31: Bipolar disorder (0.04%)
<ul>
<li>F319: Bipolar disorder, unspecified (0.04%)</li>
</ul></li>
<li>F32: Major depressive disorder, single episode (0.15%)
<ul>
<li>F322: Major depressive disorder, single episode, severe without psychotic features (0.032%)</li>
<li>F323: Major depressive disorder, single episode, severe with psychotic features (0.0012%)</li>
<li>F329: Major depressive disorder, single episode, unspecified (0.12%)</li>
</ul></li>
<li>F33: Major depressive disorder, recurrent (0.0021%)
<ul>
<li>F332: 1 Major depressv disorder, recurrent severe w/o psych features Major depressive disorder, recurrent severe without psychotic features (0.0012%)</li>
<li>F338: Other recurrent depressive disorders (0.0003%)</li>
<li>F339: Major depressive disorder, recurrent, unspecified (0.00059%)</li>
</ul></li>
<li>F39: Unspecified mood [affective] disorder (0.0003%)</li>
</ul></li>
<li>F4 (0.056%)
<ul>
<li>F41: Other anxiety disorders (0.027%)
<ul>
<li>F410: Panic disorder [episodic paroxysmal anxiety] without agoraphobia (0.0012%)</li>
<li>F411: Generalized anxiety disorder (0.0024%)</li>
<li>F412 (0.0044%)</li>
<li>F419: Anxiety disorder, unspecified (0.019%)</li>
</ul></li>
<li>F42: Obsessive-compulsive disorder (0.0003%)
<ul>
<li>F429 (0.0003%)</li>
</ul></li>
<li>F43: Reaction to severe stress, and adjustment disorders (0.024%)
<ul>
<li>F430: Acute stress reaction (0.0003%)</li>
<li>F431: Post-traumatic stress disorder (PTSD) (0.0074%)</li>
<li>F432: Adjustment disorders (0.003%)</li>
<li>F439: Reaction to severe stress, unspecified (0.014%)</li>
</ul></li>
<li>F44: Dissociative and conversion disorders (0.0018%)
<ul>
<li>F442: Dissociative stupor (0.0003%)</li>
<li>F444: Conversion disorder with motor symptom or deficit (0.00089%)</li>
<li>F448: Other dissociative and conversion disorders (0.00059%)</li>
</ul></li>
<li>F45: Somatoform disorders (0.00089%)
<ul>
<li>F450: Somatization disorder (0.0003%)</li>
<li>F453 (0.00059%)</li>
</ul></li>
<li>F48: Other nonpsychotic mental disorders (0.0018%)
<ul>
<li>F488: Other specified nonpsychotic mental disorders (0.0003%)</li>
<li>F489: Nonpsychotic mental disorder, unspecified (0.0015%)</li>
</ul></li>
</ul></li>
<li>F5 (0.12%)
<ul>
<li>F50: Eating disorders (0.032%)
<ul>
<li>F500: Anorexia nervosa (0.023%)</li>
<li>F502: Bulimia nervosa (0.005%)</li>
<li>F508: Other eating disorders (0.0024%)</li>
<li>F509: Eating disorder, unspecified (0.0018%)</li>
</ul></li>
<li>F51: 0 Sleep disorders not due to a substance or known physiol cond Sleep disorders not due to a substance or known physiological condition (0.0003%)
<ul>
<li>F519: Sleep disorder not due to a substance or known physiological condition, unspecified (0.0003%)</li>
</ul></li>
<li>F54: Psychological and behavioral factors associated with disorders or diseases classified elsewhere (0.089%)</li>
<li>F55: Abuse of non-psychoactive substances (0.00089%)</li>
<li>F59: 1 Unsp behavrl synd assoc w physiol disturb and physcl factors Unspecified behavioral syndromes associated with physiological disturbances and physical factors (0.0003%)</li>
</ul></li>
<li>F7 (0.13%)
<ul>
<li>F70: Mild intellectual disabilities (0.0003%)</li>
<li>F71: Moderate intellectual disabilities (0.0003%)</li>
<li>F72: Severe intellectual disabilities (0.019%)</li>
<li>F73: Profound intellectual disabilities (0.015%)</li>
<li>F78: Other intellectual disabilities (0.0003%)</li>
<li>F79: Unspecified intellectual disabilities (0.092%)</li>
</ul></li>
<li>F8 (0.027%)
<ul>
<li>F81: Specific developmental disorders of scholastic skills (0.0038%)
<ul>
<li>F819: Developmental disorder of scholastic skills, unspecified (0.0038%)</li>
</ul></li>
<li>F82: Specific developmental disorder of motor function (0.0003%)</li>
<li>F84: Pervasive developmental disorders (0.021%)
<ul>
<li>F840: Autistic disorder (0.0077%)</li>
<li>F842: Rett’s syndrome (0.012%)</li>
<li>F843: Other childhood disintegrative disorder (0.0003%)</li>
<li>F849: Pervasive developmental disorder, unspecified (0.0003%)</li>
</ul></li>
<li>F88: Other disorders of psychological development (0.0003%)</li>
<li>F89: Unspecified disorder of psychological development (0.0018%)</li>
</ul></li>
<li>F9 (0.01%)
<ul>
<li>F90: Attention-deficit hyperactivity disorders (0.00089%)
<ul>
<li>F900: Attention-deficit hyperactivity disorder, predominantly inattentive type (0.00089%)</li>
</ul></li>
<li>F91: Conduct disorders (0.00089%)
<ul>
<li>F919: Conduct disorder, unspecified (0.00089%)</li>
</ul></li>
<li>F95: Tic disorder (0.00089%)
<ul>
<li>F952: Tourette’s disorder (0.00089%)</li>
</ul></li>
<li>F98: 0 Oth behav/emotn disord w onset usly occur in chldhd and adol Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence (0.0003%)
<ul>
<li>F982: Other feeding disorders of infancy and childhood (0.0003%)</li>
</ul></li>
<li>F99: Mental disorder, not otherwise specified (0.0074%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
K0 (0.014%)
</summary>
<ul>
<li>K00: Disorders of tooth development and eruption (0.0012%)
<ul>
<li>K007: Teething syndrome (0.0012%)</li>
</ul></li>
<li>K02: Dental caries (0.00059%)
<ul>
<li>K029: Dental caries, unspecified (0.00059%)</li>
</ul></li>
<li>K04: Diseases of pulp and periapical tissues (0.01%)
<ul>
<li>K047: Periapical abscess without sinus (0.01%)</li>
</ul></li>
<li>K05: Gingivitis and periodontal diseases (0.0018%)
<ul>
<li>K051: Chronic gingivitis (0.0003%)</li>
<li>K052: Aggressive periodontitis (0.0012%)</li>
<li>K056: Periodontal disease, unspecified (0.0003%)</li>
</ul></li>
<li>K07 (0.0003%)
<ul>
<li>K070 (0.0003%)</li>
</ul></li>
<li>K08: Other disorders of teeth and supporting structures (0.00059%)
<ul>
<li>K089: Disorder of teeth and supporting structures, unspecified (0.00059%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
K1 (0.047%)
</summary>
<ul>
<li>K10 (0.0024%)
<ul>
<li>K102 (0.0021%)</li>
<li>K108 (0.0003%)</li>
</ul></li>
<li>K11: Diseases of salivary glands (0.032%)
<ul>
<li>K111: Hypertrophy of salivary gland (0.0003%)</li>
<li>K112: Sialoadenitis (0.027%)</li>
<li>K113: Abscess of salivary gland (0.0021%)</li>
<li>K115: Sialolithiasis (0.0003%)</li>
<li>K116: Mucocele of salivary gland (0.0003%)</li>
<li>K117: Disturbances of salivary secretion (0.0003%)</li>
<li>K119: Disease of salivary gland, unspecified (0.0015%)</li>
</ul></li>
<li>K12: Stomatitis and related lesions (0.0083%)
<ul>
<li>K120: Recurrent oral aphthae (0.0003%)</li>
<li>K121: Other forms of stomatitis (0.0015%)</li>
<li>K122: Cellulitis and abscess of mouth (0.0056%)</li>
<li>K123: Oral mucositis (ulcerative) (0.00089%)</li>
</ul></li>
<li>K13: Other diseases of lip and oral mucosa (0.0021%)
<ul>
<li>K137: Other and unspecified lesions of oral mucosa (0.0021%)</li>
</ul></li>
<li>K14: Diseases of tongue (0.0024%)
<ul>
<li>K148: Other diseases of tongue (0.0012%)</li>
<li>K149: Disease of tongue, unspecified (0.0012%)</li>
</ul></li>
</ul>
</details></li>
<li>K20: Esophagitis (0.04%)</li>
<li><details>
<summary>
K21: Gastro-esophageal reflux disease (0.16%)
</summary>
<ul>
<li>K210: Gastro-esophageal reflux disease with esophagitis (0.0086%)</li>
<li>K219: Gastro-esophageal reflux disease without esophagitis (0.15%)</li>
</ul>
</details></li>
<li><details>
<summary>
K22: Other diseases of esophagus (0.42%)
</summary>
<ul>
<li>K220: Achalasia of cardia (0.048%)</li>
<li>K221: Ulcer of esophagus (0.027%)</li>
<li>K222: Esophageal obstruction (0.1%)</li>
<li>K223: Perforation of esophagus (0.068%)</li>
<li>K224: Dyskinesia of esophagus (0.051%)</li>
<li>K225: Diverticulum of esophagus, acquired (0.022%)</li>
<li>K226: Gastro-esophageal laceration-hemorrhage syndrome (0.019%)</li>
<li>K227: Barrett’s esophagus (0.012%)</li>
<li>K228: Other specified diseases of esophagus (0.043%)</li>
<li>K229: Disease of esophagus, unspecified (0.028%)</li>
</ul>
</details></li>
<li><details>
<summary>
K29: Gastritis and duodenitis (0.074%)
</summary>
<ul>
<li>K290: Acute gastritis (0.0047%)</li>
<li>K291 (0.0018%)</li>
<li>K292: Alcoholic gastritis (0.01%)</li>
<li>K294: Chronic atrophic gastritis (0.0012%)</li>
<li>K295: Unspecified chronic gastritis (0.0056%)</li>
<li>K296: Other gastritis (0.012%)</li>
<li>K297: Gastritis, unspecified (0.034%)</li>
<li>K298: Duodenitis (0.0035%)</li>
<li>K299: Gastroduodenitis, unspecified (0.0015%)</li>
</ul>
</details></li>
<li>K30: Functional dyspepsia (0.0015%)</li>
<li><details>
<summary>
K31: Other diseases of stomach and duodenum (0.22%)
</summary>
<ul>
<li>K311: Adult hypertrophic pyloric stenosis (0.035%)</li>
<li>K312: Hourglass stricture and stenosis of stomach (0.0003%)</li>
<li>K314: Gastric diverticulum (0.0003%)</li>
<li>K315: Obstruction of duodenum (0.0032%)</li>
<li>K316: Fistula of stomach and duodenum (0.0062%)</li>
<li>K317: Polyp of stomach and duodenum (0.0018%)</li>
<li>K318: Other specified diseases of stomach and duodenum (0.12%)</li>
<li>K319: Disease of stomach and duodenum, unspecified (0.051%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>K5 (5.5%)</strong>
</summary>
<ul>
<li>K50: Crohn’s disease [regional enteritis] (0.17%)
<ul>
<li>K500: Crohn’s disease of small intestine (0.0015%)</li>
<li>K501: Crohn’s disease of large intestine (0.0032%)</li>
<li>K509: Crohn’s disease, unspecified (0.17%)</li>
</ul></li>
<li>K51: Ulcerative colitis (0.098%)
<ul>
<li>K510: Ulcerative (chronic) pancolitis (0.0015%)</li>
<li>K512: Ulcerative (chronic) proctitis (0.00059%)</li>
<li>K519: Ulcerative colitis, unspecified (0.096%)</li>
</ul></li>
<li>K52: Other and unspecified noninfective gastroenteritis and colitis (0.078%)
<ul>
<li>K520: Gastroenteritis and colitis due to radiation (0.003%)</li>
<li>K521: Toxic gastroenteritis and colitis (0.0027%)</li>
<li>K522: Allergic and dietetic gastroenteritis and colitis (0.0003%)</li>
<li>K528: Other specified noninfective gastroenteritis and colitis (0.0015%)</li>
<li>K529: Noninfective gastroenteritis and colitis, unspecified (0.071%)</li>
</ul></li>
<li><strong>K55: Vascular disorders of intestine (2.3%)</strong>
<ul>
<li>K550: Acute vascular disorders of intestine (0.45%)</li>
<li>K551: Chronic vascular disorders of intestine (0.063%)</li>
<li>K552: Angiodysplasia of colon (0.008%)</li>
<li>K558: Other vascular disorders of intestine (0.0012%)</li>
<li><strong>K559: Vascular disorder of intestine, unspecified (1.8%)</strong></li>
</ul></li>
<li><strong>K56: Paralytic ileus and intestinal obstruction without hernia (1.9%)</strong>
<ul>
<li>K560: Paralytic ileus (0.016%)</li>
<li>K561: Intussusception (0.0083%)</li>
<li>K562: Volvulus (0.18%)</li>
<li>K563: Gallstone ileus (0.0071%)</li>
<li>K564: Other impaction of intestine (0.024%)</li>
<li>K565: 1 Intestinal adhesions w obst (postprocedural) (postinfection) Intestinal adhesions [bands] with obstruction (postprocedural) (postinfection) (0.083%)</li>
<li><strong>K566: Other and unspecified intestinal obstruction (1.5%)</strong></li>
<li>K567: Ileus, unspecified (0.11%)</li>
</ul></li>
<li>K57: Diverticular disease of intestine (0.82%)
<ul>
<li>K570: Diverticulitis of small intestine with perforation and abscess (0.0027%)</li>
<li>K571: Diverticular disease of small intestine without perforation or abscess (0.0032%)</li>
<li>K572: Diverticulitis of large intestine with perforation and abscess (0.069%)</li>
<li>K573: Diverticular disease of large intestine without perforation or abscess (0.027%)</li>
<li>K578: Diverticulitis of intestine, part unspecified, with perforation and abscess (0.37%)</li>
<li>K579: 0 Diverticular disease of intest, part unsp, w/o perf or abscs Diverticular disease of intestine, part unspecified, without perforation or abscess (0.35%)</li>
</ul></li>
<li>K58: Irritable bowel syndrome (0.0056%)
<ul>
<li>K580: Irritable bowel syndrome with diarrhea (0.00059%)</li>
<li>K589: Irritable bowel syndrome without diarrhea (0.005%)</li>
</ul></li>
<li>K59: Other functional intestinal disorders (0.12%)
<ul>
<li>K590: Constipation (0.049%)</li>
<li>K592: Neurogenic bowel, not elsewhere classified (0.0018%)</li>
<li>K593: Megacolon, not elsewhere classified (0.059%)</li>
<li>K598: Other specified functional intestinal disorders (0.01%)</li>
<li>K599: Functional intestinal disorder, unspecified (0.0032%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
<strong>K6 (1.7%)</strong>
</summary>
<ul>
<li>K60: Fissure and fistula of anal and rectal regions (0.0044%)
<ul>
<li>K602: Anal fissure, unspecified (0.0003%)</li>
<li>K603: Anal fistula (0.00059%)</li>
<li>K604: Rectal fistula (0.0035%)</li>
</ul></li>
<li>K61: Abscess of anal and rectal regions (0.022%)
<ul>
<li>K610: Anal abscess (0.0018%)</li>
<li>K611: Rectal abscess (0.019%)</li>
<li>K612: Anorectal abscess (0.0003%)</li>
<li>K613: Ischiorectal abscess (0.00059%)</li>
</ul></li>
<li>K62: Other diseases of anus and rectum (0.096%)
<ul>
<li>K621: Rectal polyp (0.0003%)</li>
<li>K623: Rectal prolapse (0.0044%)</li>
<li>K624: Stenosis of anus and rectum (0.0015%)</li>
<li>K625: Hemorrhage of anus and rectum (0.047%)</li>
<li>K626: Ulcer of anus and rectum (0.0065%)</li>
<li>K627: Radiation proctitis (0.00089%)</li>
<li>K628: Other specified diseases of anus and rectum (0.008%)</li>
<li>K629: Disease of anus and rectum, unspecified (0.028%)</li>
</ul></li>
<li>K63: Other diseases of intestine (0.95%)
<ul>
<li>K630: Abscess of intestine (0.013%)</li>
<li>K631: Perforation of intestine (nontraumatic) (0.68%)</li>
<li>K632: Fistula of intestine (0.054%)</li>
<li>K633: Ulcer of intestine (0.0089%)</li>
<li>K634: Enteroptosis (0.00059%)</li>
<li>K635: Polyp of colon (0.0062%)</li>
<li>K638: Other specified diseases of intestine (0.029%)</li>
<li>K639: Disease of intestine, unspecified (0.15%)</li>
</ul></li>
<li>K65: Peritonitis (0.48%)
<ul>
<li>K650: Generalized (acute) peritonitis (0.24%)</li>
<li>K658: Other peritonitis (0.003%)</li>
<li>K659: Peritonitis, unspecified (0.23%)</li>
</ul></li>
<li>K66: Other disorders of peritoneum (0.12%)
<ul>
<li>K660: Peritoneal adhesions (postprocedural) (postinfection) (0.017%)</li>
<li>K661: Hemoperitoneum (0.062%)</li>
<li>K668: Other specified disorders of peritoneum (0.036%)</li>
<li>K669: Disorder of peritoneum, unspecified (0.0086%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
K71: Toxic liver disease (0.0027%)
</summary>
<ul>
<li>K711: Toxic liver disease with hepatic necrosis (0.0012%)</li>
<li>K716: 1 Toxic liver disease with hepatitis, not elsewhere classified Toxic liver disease with hepatitis, not elsewhere classified (0.0012%)</li>
<li>K719: Toxic liver disease, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
K72: Hepatic failure, not elsewhere classified (1.2%)
</summary>
<ul>
<li>K720: Acute and subacute hepatic failure (0.16%)</li>
<li>K721: Chronic hepatic failure (0.027%)</li>
<li>K729: Hepatic failure, unspecified (1%)</li>
</ul>
</details></li>
<li><details>
<summary>
K75: Other inflammatory liver diseases (0.26%)
</summary>
<ul>
<li>K750: Abscess of liver (0.058%)</li>
<li>K751: Phlebitis of portal vein (0.0012%)</li>
<li>K753: Granulomatous hepatitis, not elsewhere classified (0.00059%)</li>
<li>K754: Autoimmune hepatitis (0.13%)</li>
<li>K758: Other specified inflammatory liver diseases (0.0035%)</li>
<li>K759: Inflammatory liver disease, unspecified (0.068%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>K76: Other diseases of liver (2.2%)</strong>
</summary>
<ul>
<li>K760: Fatty (change of) liver, not elsewhere classified (0.49%)</li>
<li>K761: Chronic passive congestion of liver (0.011%)</li>
<li>K763: Infarction of liver (0.003%)</li>
<li>K766: Portal hypertension (0.032%)</li>
<li>K767: Hepatorenal syndrome (0.16%)</li>
<li>K768: Other specified diseases of liver (0.035%)</li>
<li><strong>K769: Liver disease, unspecified (1.5%)</strong></li>
</ul>
</details></li>
<li><details>
<summary>
K83: Other diseases of biliary tract (0.4%)
</summary>
<ul>
<li>K830: Cholangitis (0.27%)</li>
<li>K831: Obstruction of bile duct (0.099%)</li>
<li>K832: Perforation of bile duct (0.00059%)</li>
<li>K833: Fistula of bile duct (0.0012%)</li>
<li>K838: Other specified diseases of biliary tract (0.0077%)</li>
<li>K839: Disease of biliary tract, unspecified (0.013%)</li>
</ul>
</details></li>
<li><details>
<summary>
K85: Acute pancreatitis (0.82%)
</summary>
<ul>
<li>K850: Idiopathic acute pancreatitis (0.0027%)</li>
<li>K851: Biliary acute pancreatitis (0.003%)</li>
<li>K852: Alcohol induced acute pancreatitis (0.085%)</li>
<li>K858: Other acute pancreatitis (0.00059%)</li>
<li>K859: Acute pancreatitis, unspecified (0.73%)</li>
</ul>
</details></li>
<li><details>
<summary>
K86: Other diseases of pancreas (0.27%)
</summary>
<ul>
<li>K860: Alcohol-induced chronic pancreatitis (0.017%)</li>
<li>K861: Other chronic pancreatitis (0.083%)</li>
<li>K862: Cyst of pancreas (0.0038%)</li>
<li>K863: Pseudocyst of pancreas (0.012%)</li>
<li>K868: Other specified diseases of pancreas (0.019%)</li>
<li>K869: Disease of pancreas, unspecified (0.14%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>K9 (2.6%)</strong>
</summary>
<ul>
<li>K90: Intestinal malabsorption (0.072%)
<ul>
<li>K900: Celiac disease (0.0083%)</li>
<li>K901: Tropical sprue (0.0015%)</li>
<li>K902: Blind loop syndrome, not elsewhere classified (0.037%)</li>
<li>K904: Malabsorption due to intolerance, not elsewhere classified (0.0047%)</li>
<li>K908: Other intestinal malabsorption (0.00059%)</li>
<li>K909: Intestinal malabsorption, unspecified (0.02%)</li>
</ul></li>
<li>K92: Other diseases of digestive system (2.5%)
<ul>
<li>K920: Hematemesis (0.022%)</li>
<li>K921: Melena (0.0041%)</li>
<li><strong>K922: Gastrointestinal hemorrhage, unspecified (2.5%)</strong></li>
<li>K928: Other specified diseases of the digestive system (0.0083%)</li>
<li>K929: Disease of digestive system, unspecified (0.017%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
M (3.9%)
</summary>
<ul>
<li>M0 (0.79%)
<ul>
<li>M00: Pyogenic arthritis (0.13%)
<ul>
<li>M000: Staphylococcal arthritis and polyarthritis (0.0015%)</li>
<li>M002: Other streptococcal arthritis and polyarthritis (0.0003%)</li>
<li>M009: Pyogenic arthritis, unspecified (0.13%)</li>
</ul></li>
<li>M05: Rheumatoid arthritis with rheumatoid factor (0.069%)
<ul>
<li>M050: Felty’s syndrome (0.0053%)</li>
<li>M051: Rheumatoid lung disease with rheumatoid arthritis (0.044%)</li>
<li>M052: Rheumatoid vasculitis with rheumatoid arthritis (0.005%)</li>
<li>M053: Rheumatoid heart disease with rheumatoid arthritis (0.014%)</li>
</ul></li>
<li>M06: Other rheumatoid arthritis (0.59%)
<ul>
<li>M069: Rheumatoid arthritis, unspecified (0.59%)</li>
</ul></li>
<li>M08: Juvenile arthritis (0.0071%)
<ul>
<li>M080: Unspecified juvenile rheumatoid arthritis (0.0044%)</li>
<li>M082: Juvenile rheumatoid arthritis with systemic onset (0.0027%)</li>
</ul></li>
</ul></li>
<li>M1 (0.26%)
<ul>
<li>M10: Gout (0.022%)
<ul>
<li>M100: Idiopathic gout (0.0015%)</li>
<li>M109: Gout, unspecified (0.021%)</li>
</ul></li>
<li>M11: Other crystal arthropathies (0.0003%)
<ul>
<li>M112: Other chondrocalcinosis (0.0003%)</li>
</ul></li>
<li>M12: Other and unspecified arthropathy (0.0003%)
<ul>
<li>M122: Villonodular synovitis (pigmented) (0.0003%)</li>
</ul></li>
<li>M13: Other arthritis (0.059%)
<ul>
<li>M130: Polyarthritis, unspecified (0.003%)</li>
<li>M131: Monoarthritis, not elsewhere classified (0.0003%)</li>
<li>M138: Other specified arthritis (0.00089%)</li>
<li>M139 (0.055%)</li>
</ul></li>
<li>M15: Polyosteoarthritis (0.0068%)
<ul>
<li>M153: Secondary multiple arthritis (0.0003%)</li>
<li>M159: Polyosteoarthritis, unspecified (0.0065%)</li>
</ul></li>
<li>M16: Osteoarthritis of hip (0.0071%)
<ul>
<li>M169: Osteoarthritis of hip, unspecified (0.0071%)</li>
</ul></li>
<li>M17: Osteoarthritis of knee (0.0053%)
<ul>
<li>M179: Osteoarthritis of knee, unspecified (0.0053%)</li>
</ul></li>
<li>M19: Other and unspecified osteoarthritis (0.16%)
<ul>
<li>M192: Secondary osteoarthritis of other joints (0.0018%)</li>
<li>M199: Osteoarthritis, unspecified site (0.16%)</li>
</ul></li>
</ul></li>
<li>M2 (0.017%)
<ul>
<li>M21: Other acquired deformities of limbs (0.00059%)
<ul>
<li>M218: Other specified acquired deformities of limbs (0.0003%)</li>
<li>M219: Unspecified acquired deformity of limb and hand (0.0003%)</li>
</ul></li>
<li>M24: Other specific joint derangements (0.0003%)
<ul>
<li>M245: Contracture of joint (0.0003%)</li>
</ul></li>
<li>M25: Other joint disorder, not elsewhere classified (0.017%)
<ul>
<li>M250: Hemarthrosis (0.00089%)</li>
<li>M255: Pain in joint (0.0035%)</li>
<li>M257: Osteophyte (0.00059%)</li>
<li>M258: Other specified joint disorders (0.0003%)</li>
<li>M259: Joint disorder, unspecified (0.011%)</li>
</ul></li>
</ul></li>
<li><strong>M3 (1.2%)</strong>
<ul>
<li>M30: Polyarteritis nodosa and related conditions (0.017%)
<ul>
<li>M300: Polyarteritis nodosa (0.0071%)</li>
<li>M301: Polyarteritis with lung involvement [Churg-Strauss] (0.0094%)</li>
<li>M303: Mucocutaneous lymph node syndrome [Kawasaki] (0.00089%)</li>
</ul></li>
<li>M31: Other necrotizing vasculopathies (0.21%)
<ul>
<li>M310: Hypersensitivity angiitis (0.017%)</li>
<li>M311: Thrombotic microangiopathy (0.063%)</li>
<li>M313: Wegener’s granulomatosis (0.083%)</li>
<li>M314: Aortic arch syndrome [Takayasu] (0.0044%)</li>
<li>M316: Other giant cell arteritis (0.025%)</li>
<li>M317: Microscopic polyangiitis (0.011%)</li>
<li>M318: Other specified necrotizing vasculopathies (0.003%)</li>
<li>M319: Necrotizing vasculopathy, unspecified (0.0041%)</li>
</ul></li>
<li>M32: Systemic lupus erythematosus (SLE) (0.34%)
<ul>
<li>M321: Systemic lupus erythematosus with organ or system involvement (0.3%)</li>
<li>M329: Systemic lupus erythematosus, unspecified (0.039%)</li>
</ul></li>
<li>M33: Dermatopolymyositis (0.078%)
<ul>
<li>M330: Juvenile dermatopolymyositis (0.0003%)</li>
<li>M331: Other dermatopolymyositis (0.032%)</li>
<li>M332: Polymyositis (0.046%)</li>
<li>M339: Dermatopolymyositis, unspecified (0.0003%)</li>
</ul></li>
<li>M34: Systemic sclerosis [scleroderma] (0.37%)
<ul>
<li>M340: Progressive systemic sclerosis (0.0047%)</li>
<li>M341: CR(E)ST syndrome (0.027%)</li>
<li>M348: Other forms of systemic sclerosis (0.24%)</li>
<li>M349: Systemic sclerosis, unspecified (0.099%)</li>
</ul></li>
<li>M35: Other systemic involvement of connective tissue (0.14%)
<ul>
<li>M350: Sicca syndrome [Sjogren] (0.035%)</li>
<li>M351: Other overlap syndromes (0.014%)</li>
<li>M352: Behcet’s disease (0.0027%)</li>
<li>M353: Polymyalgia rheumatica (0.024%)</li>
<li>M356: Relapsing panniculitis [Weber-Christian] (0.0003%)</li>
<li>M358: Other specified systemic involvement of connective tissue (0.0035%)</li>
<li>M359: Systemic involvement of connective tissue, unspecified (0.06%)</li>
</ul></li>
</ul></li>
<li>M4 (0.34%)
<ul>
<li>M40: Kyphosis and lordosis (0.018%)
<ul>
<li>M402: Other and unspecified kyphosis (0.018%)</li>
</ul></li>
<li>M41: Scoliosis (0.066%)
<ul>
<li>M412: Other idiopathic scoliosis (0.00059%)</li>
<li>M414: Neuromuscular scoliosis (0.0003%)</li>
<li>M415: Other secondary scoliosis (0.0003%)</li>
<li>M419: Scoliosis, unspecified (0.065%)</li>
</ul></li>
<li>M43: Other deforming dorsopathies (0.0089%)
<ul>
<li>M431: Spondylolisthesis (0.0012%)</li>
<li>M432: Fusion of spine (0.0062%)</li>
<li>M436: Torticollis (0.0012%)</li>
<li>M439: Deforming dorsopathy, unspecified (0.0003%)</li>
</ul></li>
<li>M45: Ankylosing spondylitis (0.0097%)</li>
<li>M46: Other inflammatory spondylopathies (0.12%)
<ul>
<li>M460: Spinal enthesopathy (0.0003%)</li>
<li>M461: Sacroiliitis, not elsewhere classified (0.0003%)</li>
<li>M462: Osteomyelitis of vertebra (0.079%)</li>
<li>M463: Infection of intervertebral disc (pyogenic) (0.0003%)</li>
<li>M464: Discitis, unspecified (0.035%)</li>
<li>M465: Other infective spondylopathies (0.0003%)</li>
<li>M469: Unspecified inflammatory spondylopathy (0.0032%)</li>
</ul></li>
<li>M47: Spondylosis (0.017%)
<ul>
<li>M471: Other spondylosis with myelopathy (0.0038%)</li>
<li>M478: Other spondylosis (0.0083%)</li>
<li>M479: Spondylosis, unspecified (0.0047%)</li>
</ul></li>
<li>M48: Other spondylopathies (0.099%)
<ul>
<li>M480: Spinal stenosis (0.077%)</li>
<li>M481: Ankylosing hyperostosis [Forestier] (0.0012%)</li>
<li>M483: Traumatic spondylopathy (0.0003%)</li>
<li>M488: Other specified spondylopathies (0.0012%)</li>
<li>M489: Spondylopathy, unspecified (0.02%)</li>
</ul></li>
</ul></li>
<li>M5 (0.055%)
<ul>
<li>M50: Cervical disc disorders (0.0056%)
<ul>
<li>M500: Cervical disc disorder with myelopathy (0.00089%)</li>
<li>M501: Cervical disc disorder with radiculopathy (0.0003%)</li>
<li>M502: Other cervical disc displacement (0.00089%)</li>
<li>M503: Other cervical disc degeneration (0.00059%)</li>
<li>M509: Cervical disc disorder, unspecified (0.003%)</li>
</ul></li>
<li>M51: Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (0.018%)
<ul>
<li>M510: 0 Thoracic, thrclm and lumbosacr intvrt disc disord w myelpath Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with myelopathy (0.00089%)</li>
<li>M512: Other thoracic, thoracolumbar and lumbosacral intervertebral disc displacement (0.0024%)</li>
<li>M513: Other thoracic, thoracolumbar and lumbosacral intervertebral disc degeneration (0.011%)</li>
<li>M519: 1 Unsp thoracic, thoracolum and lumbosacr intvrt disc disorder Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder (0.0038%)</li>
</ul></li>
<li>M53: 0 Other and unspecified dorsopathies, not elsewhere classified Other and unspecified dorsopathies, not elsewhere classified (0.0015%)
<ul>
<li>M531: Cervicobrachial syndrome (0.0003%)</li>
<li>M532: Spinal instabilities (0.0003%)</li>
<li>M533: Sacrococcygeal disorders, not elsewhere classified (0.0003%)</li>
<li>M538: Other specified dorsopathies (0.0003%)</li>
<li>M539: Dorsopathy, unspecified (0.0003%)</li>
</ul></li>
<li>M54: Dorsalgia (0.03%)
<ul>
<li>M541: Radiculopathy (0.0027%)</li>
<li>M542: Cervicalgia (0.00059%)</li>
<li>M543: Sciatica (0.0003%)</li>
<li>M545: Low back pain (0.0041%)</li>
<li>M546: Pain in thoracic spine (0.0003%)</li>
<li>M548: Other dorsalgia (0.00059%)</li>
<li>M549: Dorsalgia, unspecified (0.022%)</li>
</ul></li>
</ul></li>
<li>M6 (0.31%)
<ul>
<li>M60: Myositis (0.057%)
<ul>
<li>M600: Infective myositis (0.012%)</li>
<li>M608: Other myositis (0.0012%)</li>
<li>M609: Myositis, unspecified (0.044%)</li>
</ul></li>
<li>M61: Calcification and ossification of muscle (0.0012%)
<ul>
<li>M611: Myositis ossificans progressiva (0.00089%)</li>
<li>M615: Other ossification of muscle (0.0003%)</li>
</ul></li>
<li>M62: Other disorders of muscle (0.25%)
<ul>
<li>M621: Other rupture of muscle (nontraumatic) (0.00059%)</li>
<li>M622: Nontraumatic ischemic infarction of muscle (0.026%)</li>
<li>M623: Immobility syndrome (paraplegic) (0.0056%)</li>
<li>M625: Muscle wasting and atrophy, not elsewhere classified (0.012%)</li>
<li>M626 (0.0012%)</li>
<li>M628: Other specified disorders of muscle (0.2%)</li>
<li>M629: Disorder of muscle, unspecified (0.0035%)</li>
</ul></li>
<li>M65: Synovitis and tenosynovitis (0.0003%)
<ul>
<li>M658: Other synovitis and tenosynovitis (0.0003%)</li>
</ul></li>
<li>M67: Other disorders of synovium and tendon (0.0003%)
<ul>
<li>M678: Other specified disorders of synovium and tendon (0.0003%)</li>
</ul></li>
</ul></li>
<li>M7 (0.22%)
<ul>
<li>M70: Soft tissue disorders related to use, overuse and pressure (0.0018%)
<ul>
<li>M702: Olecranon bursitis (0.0018%)</li>
</ul></li>
<li>M71: Other bursopathies (0.0024%)
<ul>
<li>M711: Other infective bursitis (0.0018%)</li>
<li>M719: Bursopathy, unspecified (0.00059%)</li>
</ul></li>
<li>M72: Fibroblastic disorders (0.2%)
<ul>
<li>M720: Palmar fascial fibromatosis [Dupuytren] (0.0003%)</li>
<li>M726: Necrotizing fasciitis (0.19%)</li>
<li>M729: Fibroblastic disorder, unspecified (0.0097%)</li>
</ul></li>
<li>M75: Shoulder lesions (0.0003%)
<ul>
<li>M751: Rotator cuff tear or rupture, not specified as traumatic (0.0003%)</li>
</ul></li>
<li>M77: Other enthesopathies (0.0003%)
<ul>
<li>M779: Enthesopathy, unspecified (0.0003%)</li>
</ul></li>
<li>M79: 0 Oth and unsp soft tissue disorders, not elsewhere classified Other and unspecified soft tissue disorders, not elsewhere classified (0.018%)
<ul>
<li>M791: Myalgia (0.00059%)</li>
<li>M792: Neuralgia and neuritis, unspecified (0.00059%)</li>
<li>M793: Panniculitis, unspecified (0.0074%)</li>
<li>M796: Pain in limb, hand, foot, fingers and toes (0.0021%)</li>
<li>M797: Fibromyalgia (0.0062%)</li>
<li>M798: Other specified soft tissue disorders (0.00059%)</li>
<li>M799: Soft tissue disorder, unspecified (0.00059%)</li>
</ul></li>
</ul></li>
<li>M8 (0.79%)
<ul>
<li>M80: Osteoporosis with current pathological fracture (0.13%)
<ul>
<li>M800: Age-related osteoporosis with current pathological fracture (0.00059%)</li>
<li>M802 (0.0003%)</li>
<li>M808: Other osteoporosis with current pathological fracture (0.0003%)</li>
<li>M809 (0.12%)</li>
</ul></li>
<li>M81: Osteoporosis without current pathological fracture (0.12%)
<ul>
<li>M815 (0.0003%)</li>
<li>M818: Other osteoporosis without current pathological fracture (0.0035%)</li>
<li>M819 (0.12%)</li>
</ul></li>
<li>M83: Adult osteomalacia (0.00059%)
<ul>
<li>M838: Other adult osteomalacia (0.0003%)</li>
<li>M839: Adult osteomalacia, unspecified (0.0003%)</li>
</ul></li>
<li>M84: Disorder of continuity of bone (0.025%)
<ul>
<li>M840 (0.0003%)</li>
<li>M841 (0.00059%)</li>
<li>M844: Pathological fracture, not elsewhere classified (0.024%)</li>
</ul></li>
<li>M85: Other disorders of bone density and structure (0.00059%)
<ul>
<li>M855: Aneurysmal bone cyst (0.0003%)</li>
<li>M858: Other specified disorders of bone density and structure (0.0003%)</li>
</ul></li>
<li>M86: Osteomyelitis (0.48%)
<ul>
<li>M861: Other acute osteomyelitis (0.0077%)</li>
<li>M863: Chronic multifocal osteomyelitis (0.0003%)</li>
<li>M866: Other chronic osteomyelitis (0.037%)</li>
<li>M868: Other osteomyelitis (0.0059%)</li>
<li>M869: Osteomyelitis, unspecified (0.43%)</li>
</ul></li>
<li>M87: Osteonecrosis (0.0086%)
<ul>
<li>M878: Other osteonecrosis (0.0015%)</li>
<li>M879: Osteonecrosis, unspecified (0.0071%)</li>
</ul></li>
<li>M88: Osteitis deformans [Paget’s disease of bone] (0.0071%)
<ul>
<li>M889: Osteitis deformans of unspecified bone (0.0071%)</li>
</ul></li>
<li>M89: Other disorders of bone (0.017%)
<ul>
<li>M890: Algoneurodystrophy (0.0021%)</li>
<li>M898: Other specified disorders of bone (0.0074%)</li>
<li>M899: Disorder of bone, unspecified (0.0074%)</li>
</ul></li>
</ul></li>
<li>M9 (0.0047%)
<ul>
<li>M91: Juvenile osteochondrosis of hip and pelvis (0.00059%)
<ul>
<li>M910: Juvenile osteochondrosis of pelvis (0.0003%)</li>
<li>M911: Juvenile osteochondrosis of head of femur [Legg-Calve-Perthes] (0.0003%)</li>
</ul></li>
<li>M93: Other osteochondropathies (0.0003%)
<ul>
<li>M939: Osteochondropathy, unspecified (0.0003%)</li>
</ul></li>
<li>M94: Other disorders of cartilage (0.003%)
<ul>
<li>M941: Relapsing polychondritis (0.0012%)</li>
<li>M942: Chondromalacia (0.00059%)</li>
<li>M948: Other specified disorders of cartilage (0.00089%)</li>
<li>M949: Disorder of cartilage, unspecified (0.0003%)</li>
</ul></li>
<li>M95: Other acquired deformities of musculoskeletal system and connective tissue (0.00089%)
<ul>
<li>M954: Acquired deformity of chest and rib (0.00059%)</li>
<li>M959: Acquired deformity of musculoskeletal system, unspecified (0.0003%)</li>
</ul></li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li>N130 (0.0015%)</li>
<li>N131: Hydronephrosis with ureteral stricture, not elsewhere classified (0.0003%)</li>
<li>N132: 1 Hydronephrosis with renal and ureteral calculous obstruction Hydronephrosis with renal and ureteral calculous obstruction (0.0077%)</li>
<li>N133: Other and unspecified hydronephrosis (0.046%)</li>
<li>N134: Hydroureter (0.00089%)</li>
<li>N135: Crossing vessel and stricture of ureter without hydronephrosis (0.017%)</li>
<li>N137: Vesicoureteral-reflux (0.0015%)</li>
<li>N138: Other obstructive and reflux uropathy (0.0044%)</li>
<li>N139: Obstructive and reflux uropathy, unspecified (0.074%)</li>
<li><details>
<summary>
N14: 0 Drug- &amp; heavy-metal-induced tubulo-interstitial &amp; tublr cond Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions (0.0053%)
</summary>
<ul>
<li>N140: Analgesic nephropathy (0.0003%)</li>
<li>N141: Nephropathy induced by other drugs, medicaments and biological substances (0.0018%)</li>
<li>N142: Nephropathy induced by unspecified drug, medicament or biological substance (0.0024%)</li>
<li>N144: Toxic nephropathy, not elsewhere classified (0.00089%)</li>
</ul>
</details></li>
<li>N150: Balkan nephropathy (0.0003%)</li>
<li>N159: Renal tubulo-interstitial disease, unspecified (0.0056%)</li>
<li><details>
<summary>
N20: Calculus of kidney and ureter (0.12%)
</summary>
<ul>
<li>N200: Calculus of kidney (0.096%)</li>
<li>N201: Calculus of ureter (0.015%)</li>
<li>N202: Calculus of kidney with calculus of ureter (0.00089%)</li>
<li>N209: Urinary calculus, unspecified (0.0083%)</li>
</ul>
</details></li>
<li><details>
<summary>
N21: Calculus of lower urinary tract (0.0035%)
</summary>
<ul>
<li>N210: Calculus in bladder (0.0018%)</li>
<li>N211: Calculus in urethra (0.0018%)</li>
</ul>
</details></li>
<li><details>
<summary>
N28: 0 Oth disorders of kidney and ureter, not elsewhere classified Other disorders of kidney and ureter, not elsewhere classified (0.83%)
</summary>
<ul>
<li>N280: Ischemia and infarction of kidney (0.0071%)</li>
<li>N281: Cyst of kidney, acquired (0.0003%)</li>
<li>N288: Other specified disorders of kidney and ureter (0.55%)</li>
<li>N289: Disorder of kidney and ureter, unspecified (0.27%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>N3 (3.6%)</strong>
</summary>
<ul>
<li>N30: Cystitis (0.034%)
<ul>
<li>N300: Acute cystitis (0.0071%)</li>
<li>N302: Other chronic cystitis (0.0021%)</li>
<li>N304: Irradiation cystitis (0.0032%)</li>
<li>N308: Other cystitis (0.003%)</li>
<li>N309: Cystitis, unspecified (0.019%)</li>
</ul></li>
<li>N31: Neuromuscular dysfunction of bladder, not elsewhere classified (0.028%)
<ul>
<li>N312: Flaccid neuropathic bladder, not elsewhere classified (0.0015%)</li>
<li>N319: Neuromuscular dysfunction of bladder, unspecified (0.027%)</li>
</ul></li>
<li>N32: Other disorders of bladder (0.081%)
<ul>
<li>N320: Bladder-neck obstruction (0.014%)</li>
<li>N321: Vesicointestinal fistula (0.035%)</li>
<li>N322: Vesical fistula, not elsewhere classified (0.00089%)</li>
<li>N323: Diverticulum of bladder (0.00059%)</li>
<li>N324 (0.0074%)</li>
<li>N328: Other specified disorders of bladder (0.0024%)</li>
<li>N329: Bladder disorder, unspecified (0.021%)</li>
</ul></li>
<li>N34: Urethritis and urethral syndrome (0.0003%)
<ul>
<li>N342: Other urethritis (0.0003%)</li>
</ul></li>
<li>N35: Urethral stricture (0.003%)
<ul>
<li>N359: Urethral stricture, unspecified (0.003%)</li>
</ul></li>
<li>N36: Other disorders of urethra (0.0041%)
<ul>
<li>N360: Urethral fistula (0.0021%)</li>
<li>N368: Other specified disorders of urethra (0.0018%)</li>
<li>N369: Urethral disorder, unspecified (0.0003%)</li>
</ul></li>
<li><strong>N39: Other disorders of urinary system (3.5%)</strong>
<ul>
<li>N390: Urinary tract infection, site not specified (3.4%)</li>
<li>N399: Disorder of urinary system, unspecified (0.0027%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
N41: Inflammatory diseases of prostate (0.008%)
</summary>
<ul>
<li>N410: Acute prostatitis (0.0012%)</li>
<li>N411: Chronic prostatitis (0.00089%)</li>
<li>N412: Abscess of prostate (0.0015%)</li>
<li>N413: Prostatocystitis (0.0003%)</li>
<li>N418: Other inflammatory diseases of prostate (0.0003%)</li>
<li>N419: Inflammatory disease of prostate, unspecified (0.0038%)</li>
</ul>
</details></li>
<li><details>
<summary>
N42: Other and unspecified disorders of prostate (0.014%)
</summary>
<ul>
<li>N421: Congestion and hemorrhage of prostate (0.00089%)</li>
<li>N428: Other specified disorders of prostate (0.0003%)</li>
<li>N429: Disorder of prostate, unspecified (0.013%)</li>
</ul>
</details></li>
<li><details>
<summary>
N43: Hydrocele and spermatocele (0.0003%)
</summary>
<ul>
<li>N433: Hydrocele, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
N45: Orchitis and epididymitis (0.0015%)
</summary>
<ul>
<li>N459 (0.0015%)</li>
</ul>
</details></li>
<li>N47: Disorders of prepuce (0.0003%)</li>
<li><details>
<summary>
N48: Other disorders of penis (0.0065%)
</summary>
<ul>
<li>N481: Balanitis (0.0003%)</li>
<li>N482: Other inflammatory disorders of penis (0.0056%)</li>
<li>N488: Other specified disorders of penis (0.0003%)</li>
<li>N489: Disorder of penis, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
N49: Inflammatory disorders of male genital organs, not elsewhere classified (0.054%)
</summary>
<ul>
<li>N492: Inflammatory disorders of scrotum (0.011%)</li>
<li>N498: Inflammatory disorders of other specified male genital organs (0.043%)</li>
<li>N499: Inflammatory disorder of unspecified male genital organ (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
N5 (0.0038%)
</summary>
<ul>
<li>N50: Other and unspecified disorders of male genital organs (0.0038%)
<ul>
<li>N501: Vascular disorders of male genital organs (0.0015%)</li>
<li>N508: Other specified disorders of male genital organs (0.00059%)</li>
<li>N509: Disorder of male genital organs, unspecified (0.0018%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
N6 (0.027%)
</summary>
<ul>
<li>N61: Inflammatory disorders of breast (0.0038%)</li>
<li>N63: Unspecified lump in breast (0.018%)</li>
<li>N64: Other disorders of breast (0.005%)
<ul>
<li>N641: Fat necrosis of breast (0.00059%)</li>
<li>N649: Disorder of breast, unspecified (0.0044%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
N7 (0.038%)
</summary>
<ul>
<li>N70: Salpingitis and oophoritis (0.0038%)
<ul>
<li>N700: Acute salpingitis and oophoritis (0.00059%)</li>
<li>N701: Chronic salpingitis and oophoritis (0.0003%)</li>
<li>N709: Salpingitis and oophoritis, unspecified (0.003%)</li>
</ul></li>
<li>N71: Inflammatory disease of uterus, except cervix (0.0032%)
<ul>
<li>N719: Inflammatory disease of uterus, unspecified (0.0032%)</li>
</ul></li>
<li>N73: Other female pelvic inflammatory diseases (0.024%)
<ul>
<li>N730: Acute parametritis and pelvic cellulitis (0.0003%)</li>
<li>N739: Female pelvic inflammatory disease, unspecified (0.024%)</li>
</ul></li>
<li>N76: Other inflammation of vagina and vulva (0.0071%)
<ul>
<li>N760: Acute vaginitis (0.00089%)</li>
<li>N762: Acute vulvitis (0.0003%)</li>
<li>N764: Abscess of vulva (0.0018%)</li>
<li>N768: Other specified inflammation of vagina and vulva (0.0041%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
N8 (0.06%)
</summary>
<ul>
<li>N80: Endometriosis (0.0012%)
<ul>
<li>N800: Endometriosis of uterus (0.0003%)</li>
<li>N808: Other endometriosis (0.0003%)</li>
<li>N809: Endometriosis, unspecified (0.00059%)</li>
</ul></li>
<li>N81: Female genital prolapse (0.0059%)
<ul>
<li>N810: Urethrocele (0.0003%)</li>
<li>N811: Cystocele (0.0038%)</li>
<li>N814: Uterovaginal prolapse, unspecified (0.0012%)</li>
<li>N816: Rectocele (0.0003%)</li>
<li>N818: Other female genital prolapse (0.0003%)</li>
</ul></li>
<li>N82: Fistulae involving female genital tract (0.017%)
<ul>
<li>N821: Other female urinary-genital tract fistulae (0.0012%)</li>
<li>N823: Fistula of vagina to large intestine (0.014%)</li>
<li>N824: Other female intestinal-genital tract fistulae (0.0024%)</li>
<li>N829: Female genital tract fistula, unspecified (0.0003%)</li>
</ul></li>
<li>N83: Noninflammatory disorders of ovary, fallopian tube and broad ligament (0.022%)
<ul>
<li>N832: Other and unspecified ovarian cysts (0.0015%)</li>
<li>N839: Noninflammatory disorder of ovary, fallopian tube and broad ligament, unspecified (0.021%)</li>
</ul></li>
<li>N85: Other noninflammatory disorders of uterus, except cervix (0.0091%)
<ul>
<li>N850: Endometrial hyperplasia (0.00089%)</li>
<li>N858: Other specified noninflammatory disorders of uterus (0.0021%)</li>
<li>N859: Noninflammatory disorder of uterus, unspecified (0.0062%)</li>
</ul></li>
<li>N87: Dysplasia of cervix uteri (0.0003%)
<ul>
<li>N879: Dysplasia of cervix uteri, unspecified (0.0003%)</li>
</ul></li>
<li>N88: Other noninflammatory disorders of cervix uteri (0.0035%)
<ul>
<li>N882: Stricture and stenosis of cervix uteri (0.003%)</li>
<li>N883: Incompetence of cervix uteri (0%)</li>
<li>N888: Other specified noninflammatory disorders of cervix uteri (0.0003%)</li>
<li>N889: Noninflammatory disorder of cervix uteri, unspecified (0.0003%)</li>
</ul></li>
<li>N89: Other noninflammatory disorders of vagina (0.0003%)
<ul>
<li>N899: Noninflammatory disorder of vagina, unspecified (0.0003%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
N9 (0.015%)
</summary>
<ul>
<li>N90: Other noninflammatory disorders of vulva and perineum (0.00059%)
<ul>
<li>N908: Other specified noninflammatory disorders of vulva and perineum (0.0003%)</li>
<li>N909: Noninflammatory disorder of vulva and perineum, unspecified (0.0003%)</li>
</ul></li>
<li>N92: Excessive, frequent and irregular menstruation (0.0003%)
<ul>
<li>N926: Irregular menstruation, unspecified (0.0003%)</li>
</ul></li>
<li>N93: Other abnormal uterine and vaginal bleeding (0.0089%)
<ul>
<li>N938: Other specified abnormal uterine and vaginal bleeding (0.0003%)</li>
<li>N939: Abnormal uterine and vaginal bleeding, unspecified (0.0086%)</li>
</ul></li>
<li>N94: Pain and other conditions associated with female genital organs and menstrual cycle (0.003%)
<ul>
<li>N948: Other specified conditions associated with female genital organs and menstrual cycle (0.0027%)</li>
<li>N949: Unspecified condition associated with female genital organs and menstrual cycle (0.0003%)</li>
</ul></li>
<li>N95: Menopausal and other perimenopausal disorders (0.0024%)
<ul>
<li>N950: Postmenopausal bleeding (0.0018%)</li>
<li>N952: Postmenopausal atrophic vaginitis (0.0003%)</li>
<li>N959: Unspecified menopausal and perimenopausal disorder (0.0003%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
G04: Encephalitis, myelitis and encephalomyelitis (0.093%)
</summary>
<ul>
<li>G040: 0 Acute disseminated encephalitis and encephalomyelitis (ADEM) Acute disseminated encephalitis and encephalomyelitis (ADEM) (0.0018%)</li>
<li>G042: Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified (0.0021%)</li>
<li>G048: Other encephalitis, myelitis and encephalomyelitis (0.0024%)</li>
<li>G049: Encephalitis, myelitis and encephalomyelitis, unspecified (0.087%)</li>
</ul>
</details></li>
<li><details>
<summary>
G06: Intracranial and intraspinal abscess and granuloma (0.093%)
</summary>
<ul>
<li>G060: Intracranial abscess and granuloma (0.042%)</li>
<li>G061: Intraspinal abscess and granuloma (0.01%)</li>
<li>G062: Extradural and subdural abscess, unspecified (0.04%)</li>
</ul>
</details></li>
<li>G08: Intracranial and intraspinal phlebitis and thrombophlebitis (0.011%)</li>
<li>G09: Sequelae of inflammatory diseases of central nervous system (0.028%)</li>
<li><details>
<summary>
<strong>G1 (2.6%)</strong>
</summary>
<ul>
<li>G10: Huntington’s disease (0.32%)</li>
<li>G11: Hereditary ataxia (0.088%)
<ul>
<li>G111: Early-onset cerebellar ataxia (0.04%)</li>
<li>G113: Cerebellar ataxia with defective DNA repair (0.0015%)</li>
<li>G114: Hereditary spastic paraplegia (0.0047%)</li>
<li>G119: Hereditary ataxia, unspecified (0.042%)</li>
</ul></li>
<li>G12: Spinal muscular atrophy and related syndromes (2.2%)
<ul>
<li>G120: Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] (0.0038%)</li>
<li>G121: Other inherited spinal muscular atrophy (0.003%)</li>
<li>G122: Motor neuron disease (2.1%)</li>
<li>G129: Spinal muscular atrophy, unspecified (0.031%)</li>
</ul></li>
<li>G14: Postpolio syndrome (0.036%)</li>
</ul>
</details></li>
<li><details>
<summary>
G23: Other degenerative diseases of basal ganglia (0.088%)
</summary>
<ul>
<li>G230: Hallervorden-Spatz disease (0.00059%)</li>
<li>G231: Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski] (0.012%)</li>
<li>G232: Striatonigral degeneration (0.0015%)</li>
<li>G238: Other specified degenerative diseases of basal ganglia (0.023%)</li>
<li>G239: Degenerative disease of basal ganglia, unspecified (0.05%)</li>
</ul>
</details></li>
<li><details>
<summary>
G24: Dystonia (0.017%)
</summary>
<ul>
<li>G241: Genetic torsion dystonia (0.0021%)</li>
<li>G243: Spasmodic torticollis (0.0003%)</li>
<li>G244: Idiopathic orofacial dystonia (0.0056%)</li>
<li>G248: Other dystonia (0.0015%)</li>
<li>G249: Dystonia, unspecified (0.008%)</li>
</ul>
</details></li>
<li><details>
<summary>
G25: Other extrapyramidal and movement disorders (0.026%)
</summary>
<ul>
<li>G250: Essential tremor (0.0024%)</li>
<li>G252: Other specified forms of tremor (0.0003%)</li>
<li>G253: Myoclonus (0.0044%)</li>
<li>G255: Other chorea (0.0041%)</li>
<li>G258: Other specified extrapyramidal and movement disorders (0.0077%)</li>
<li>G259: Extrapyramidal and movement disorder, unspecified (0.0068%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>G31: Other degenerative diseases of nervous system, not elsewhere classified (2.8%)</strong>
</summary>
<ul>
<li>G310: Frontotemporal dementia (0.31%)</li>
<li>G311: Senile degeneration of brain, not elsewhere classified (0.6%)</li>
<li>G312: Degeneration of nervous system due to alcohol (0.046%)</li>
<li><strong>G318: Other specified degenerative diseases of nervous system (1%)</strong></li>
<li>G319: Degenerative disease of nervous system, unspecified (0.83%)</li>
</ul>
</details></li>
<li><strong>G35: Multiple sclerosis (1.2%)</strong></li>
<li><details>
<summary>
G36: Other acute disseminated demyelination (0.013%)
</summary>
<ul>
<li>G360: Neuromyelitis optica [Devic] (0.012%)</li>
<li>G361: Acute and subacute hemorrhagic leukoencephalitis [Hurst] (0.00059%)</li>
<li>G369: Acute disseminated demyelination, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
G37: Other demyelinating diseases of central nervous system (0.051%)
</summary>
<ul>
<li>G370: Diffuse sclerosis of central nervous system (0.00089%)</li>
<li>G371: Central demyelination of corpus callosum (0.00059%)</li>
<li>G372: Central pontine myelinolysis (0.0089%)</li>
<li>G373: Acute transverse myelitis in demyelinating disease of central nervous system (0.024%)</li>
<li>G378: Other specified demyelinating diseases of central nervous system (0.0015%)</li>
<li>G379: 1 Demyelinating disease of central nervous system, unspecified Demyelinating disease of central nervous system, unspecified (0.015%)</li>
</ul>
</details></li>
<li><details>
<summary>
G4 (1%)
</summary>
<ul>
<li>G40: Epilepsy and recurrent seizures (0.37%)
<ul>
<li>G401: Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures (0.0015%)</li>
<li>G402: 0 Local-rel (focal) symptc epilepsy w complex partial seizures Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures (0.0012%)</li>
<li>G403: Generalized idiopathic epilepsy and epileptic syndromes (0.018%)</li>
<li>G404: Other generalized epilepsy and epileptic syndromes (0.014%)</li>
<li>G406 (0.025%)</li>
<li>G407 (0.0003%)</li>
<li>G408: Other epilepsy and recurrent seizures (0.0012%)</li>
<li>G409: Epilepsy, unspecified (0.31%)</li>
</ul></li>
<li>G41 (0.26%)
<ul>
<li>G412 (0.0003%)</li>
<li>G418 (0.00059%)</li>
<li>G419 (0.26%)</li>
</ul></li>
<li>G43: Migraine (0.00059%)
<ul>
<li>G439: Migraine, unspecified (0.00059%)</li>
</ul></li>
<li>G45: Transient cerebral ischemic attacks and related syndromes (0.058%)
<ul>
<li>G450: Vertebro-basilar artery syndrome (0.0015%)</li>
<li>G459: Transient cerebral ischemic attack, unspecified (0.056%)</li>
</ul></li>
<li>G47: Sleep disorders (0.32%)
<ul>
<li>G470: Insomnia (0.00059%)</li>
<li>G471: Hypersomnia (0.00089%)</li>
<li>G473: Sleep apnea (0.32%)</li>
<li>G474: Narcolepsy and cataplexy (0.00089%)</li>
<li>G479: Sleep disorder, unspecified (0.00059%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
G5 (0.012%)
</summary>
<ul>
<li>G50: Disorders of trigeminal nerve (0.0018%)
<ul>
<li>G500: Trigeminal neuralgia (0.0018%)</li>
</ul></li>
<li>G51: Facial nerve disorders (0.0015%)
<ul>
<li>G510: Bell’s palsy (0.0015%)</li>
</ul></li>
<li>G52: Disorders of other cranial nerves (0.0024%)
<ul>
<li>G521: Disorders of glossopharyngeal nerve (0.00059%)</li>
<li>G522: Disorders of vagus nerve (0.0012%)</li>
<li>G527: Disorders of multiple cranial nerves (0.0003%)</li>
<li>G528: Disorders of other specified cranial nerves (0.0003%)</li>
</ul></li>
<li>G54: Nerve root and plexus disorders (0.00059%)
<ul>
<li>G542: Cervical root disorders, not elsewhere classified (0.0003%)</li>
<li>G545: Neuralgic amyotrophy (0.0003%)</li>
</ul></li>
<li>G58: Other mononeuropathies (0.0059%)
<ul>
<li>G587: Mononeuritis multiplex (0.0003%)</li>
<li>G588: Other specified mononeuropathies (0.00089%)</li>
<li>G589: Mononeuropathy, unspecified (0.0047%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
G6 (0.22%)
</summary>
<ul>
<li>G60: Hereditary and idiopathic neuropathy (0.037%)
<ul>
<li>G600: Hereditary motor and sensory neuropathy (0.022%)</li>
<li>G603: Idiopathic progressive neuropathy (0.003%)</li>
<li>G608: Other hereditary and idiopathic neuropathies (0.0024%)</li>
<li>G609: Hereditary and idiopathic neuropathy, unspecified (0.0094%)</li>
</ul></li>
<li>G61: Inflammatory polyneuropathy (0.092%)
<ul>
<li>G610: Guillain-Barre syndrome (0.065%)</li>
<li>G618: Other inflammatory polyneuropathies (0.027%)</li>
</ul></li>
<li>G62: Other and unspecified polyneuropathies (0.094%)
<ul>
<li>G621: Alcoholic polyneuropathy (0.0012%)</li>
<li>G622: Polyneuropathy due to other toxic agents (0.0003%)</li>
<li>G628: Other specified polyneuropathies (0.017%)</li>
<li>G629: Polyneuropathy, unspecified (0.076%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
G7 (0.71%)
</summary>
<ul>
<li>G70: Myasthenia gravis and other myoneural disorders (0.3%)
<ul>
<li>G700: Myasthenia gravis (0.22%)</li>
<li>G701: Toxic myoneural disorders (0.0003%)</li>
<li>G702: Congenital and developmental myasthenia (0.00059%)</li>
<li>G708: Other specified myoneural disorders (0.00059%)</li>
<li>G709: Myoneural disorder, unspecified (0.076%)</li>
</ul></li>
<li>G71: Primary disorders of muscles (0.37%)
<ul>
<li>G710: Muscular dystrophy (0.25%)</li>
<li>G711: Myotonic disorders (0.078%)</li>
<li>G712: Congenital myopathies (0.026%)</li>
<li>G713: Mitochondrial myopathy, not elsewhere classified (0.0094%)</li>
<li>G718: Other primary disorders of muscles (0.0044%)</li>
<li>G719: Primary disorder of muscle, unspecified (0.00059%)</li>
</ul></li>
<li>G72: Other and unspecified myopathies (0.045%)
<ul>
<li>G720: Drug-induced myopathy (0.0021%)</li>
<li>G721: Alcoholic myopathy (0.0003%)</li>
<li>G723: Periodic paralysis (0.0003%)</li>
<li>G724: 0 Inflammatory and immune myopathies, not elsewhere classified Inflammatory and immune myopathies, not elsewhere classified (0.0041%)</li>
<li>G728: Other specified myopathies (0.005%)</li>
<li>G729: Myopathy, unspecified (0.033%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
G8 (0.81%)
</summary>
<ul>
<li>G80: Cerebral palsy (0.52%)
<ul>
<li>G800: Spastic quadriplegic cerebral palsy (0.00089%)</li>
<li>G801: Spastic diplegic cerebral palsy (0.005%)</li>
<li>G802: Spastic hemiplegic cerebral palsy (0.0003%)</li>
<li>G803: Athetoid cerebral palsy (0.0015%)</li>
<li>G808: Other cerebral palsy (0.023%)</li>
<li>G809: Cerebral palsy, unspecified (0.49%)</li>
</ul></li>
<li>G81: Hemiplegia and hemiparesis (0.021%)
<ul>
<li>G811: Spastic hemiplegia (0.0003%)</li>
<li>G819: Hemiplegia, unspecified (0.02%)</li>
</ul></li>
<li>G82: Paraplegia (paraparesis) and quadriplegia (quadriparesis) (0.24%)
<ul>
<li>G821 (0.003%)</li>
<li>G822: Paraplegia (0.093%)</li>
<li>G823 (0.0003%)</li>
<li>G824 (0.015%)</li>
<li>G825: Quadriplegia (0.13%)</li>
</ul></li>
<li>G83: Other paralytic syndromes (0.033%)
<ul>
<li>G830: Diplegia of upper limbs (0.00059%)</li>
<li>G831: Monoplegia of lower limb (0.0012%)</li>
<li>G834: Cauda equina syndrome (0.0041%)</li>
<li>G838: Other specified paralytic syndromes (0.012%)</li>
<li>G839: Paralytic syndrome, unspecified (0.014%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
<strong>G9 (3.5%)</strong>
</summary>
<ul>
<li>G90: Disorders of autonomic nervous system (0.076%)
<ul>
<li>G900: Idiopathic peripheral autonomic neuropathy (0.0018%)</li>
<li>G901: Familial dysautonomia [Riley-Day] (0.0077%)</li>
<li>G902: Horner’s syndrome (0.0003%)</li>
<li>G903: Multi-system degeneration of the autonomic nervous system (0.035%)</li>
<li>G904: Autonomic dysreflexia (0.0027%)</li>
<li>G908: Other disorders of autonomic nervous system (0.022%)</li>
<li>G909: Disorder of the autonomic nervous system, unspecified (0.0065%)</li>
</ul></li>
<li>G91: Hydrocephalus (0.23%)
<ul>
<li>G910: Communicating hydrocephalus (0.0012%)</li>
<li>G911: Obstructive hydrocephalus (0.031%)</li>
<li>G912: (Idiopathic) normal pressure hydrocephalus (0.086%)</li>
<li>G918: Other hydrocephalus (0.0018%)</li>
<li>G919: Hydrocephalus, unspecified (0.11%)</li>
</ul></li>
<li>G92: Toxic encephalopathy (0.071%)</li>
<li><strong>G93: Other disorders of brain (3%)</strong>
<ul>
<li>G930: Cerebral cysts (0.0068%)</li>
<li><strong>G931: Anoxic brain damage, not elsewhere classified (2%)</strong></li>
<li>G932: Benign intracranial hypertension (0.014%)</li>
<li>G933: Postviral fatigue syndrome (0.00089%)</li>
<li>G934: Other and unspecified encephalopathy (0.62%)</li>
<li>G935: Compression of brain (0.094%)</li>
<li>G936: Cerebral edema (0.1%)</li>
<li>G937: Reye’s syndrome (0.0012%)</li>
<li>G938: Other specified disorders of brain (0.04%)</li>
<li>G939: Disorder of brain, unspecified (0.096%)</li>
</ul></li>
<li>G95: Other and unspecified diseases of spinal cord (0.075%)
<ul>
<li>G950: Syringomyelia and syringobulbia (0.0062%)</li>
<li>G951: Vascular myelopathies (0.014%)</li>
<li>G952: Other and unspecified cord compression (0.014%)</li>
<li>G958: Other specified diseases of spinal cord (0.0041%)</li>
<li>G959: Disease of spinal cord, unspecified (0.037%)</li>
</ul></li>
<li>G96: Other disorders of central nervous system (0.016%)
<ul>
<li>G960: Cerebrospinal fluid leak (0.0012%)</li>
<li>G961: Disorders of meninges, not elsewhere classified (0.0059%)</li>
<li>G968: Other specified disorders of central nervous system (0.0024%)</li>
<li>G969: Disorder of central nervous system, unspecified (0.0062%)</li>
</ul></li>
<li>G98: Other disorders of nervous system not elsewhere classified (0.019%)</li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
E0 (0.59%)
</summary>
<ul>
<li>E00: Congenital iodine-deficiency syndrome (0.00059%)
<ul>
<li>E009: Congenital iodine-deficiency syndrome, unspecified (0.00059%)</li>
</ul></li>
<li>E03: Other hypothyroidism (0.47%)
<ul>
<li>E031: Congenital hypothyroidism without goiter (0.00089%)</li>
<li>E035: Myxedema coma (0.02%)</li>
<li>E038: Other specified hypothyroidism (0.0003%)</li>
<li>E039: Hypothyroidism, unspecified (0.45%)</li>
</ul></li>
<li>E04: Other nontoxic goiter (0.013%)
<ul>
<li>E041: Nontoxic single thyroid nodule (0.0012%)</li>
<li>E042: Nontoxic multinodular goiter (0.0021%)</li>
<li>E049: Nontoxic goiter, unspecified (0.01%)</li>
</ul></li>
<li>E05: Thyrotoxicosis [hyperthyroidism] (0.078%)
<ul>
<li>E050: Thyrotoxicosis with diffuse goiter (0.011%)</li>
<li>E052: Thyrotoxicosis with toxic multinodular goiter (0.00089%)</li>
<li>E055 (0.0083%)</li>
<li>E059: Thyrotoxicosis, unspecified (0.058%)</li>
</ul></li>
<li>E06: Thyroiditis (0.0077%)
<ul>
<li>E063: Autoimmune thyroiditis (0.0059%)</li>
<li>E065: Other chronic thyroiditis (0.00059%)</li>
<li>E069: Thyroiditis, unspecified (0.0012%)</li>
</ul></li>
<li>E07: Other disorders of thyroid (0.018%)
<ul>
<li>E078: Other specified disorders of thyroid (0.0003%)</li>
<li>E079: Disorder of thyroid, unspecified (0.018%)</li>
</ul></li>
</ul>
</details></li>
<li>E15: Nondiabetic hypoglycemic coma (0.0059%)</li>
<li><details>
<summary>
E16: Other disorders of pancreatic internal secretion (0.11%)
</summary>
<ul>
<li>E160: Drug-induced hypoglycemia without coma (0.00059%)</li>
<li>E161: Other hypoglycemia (0.0003%)</li>
<li>E162: Hypoglycemia, unspecified (0.11%)</li>
<li>E164: Increased secretion of gastrin (0.0021%)</li>
<li>E169: Disorder of pancreatic internal secretion, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
E2 (0.16%)
</summary>
<ul>
<li>E20: Hypoparathyroidism (0.00089%)
<ul>
<li>E209: Hypoparathyroidism, unspecified (0.00089%)</li>
</ul></li>
<li>E21: 0 Hyperparathyroidism and other disorders of parathyroid gland Hyperparathyroidism and other disorders of parathyroid gland (0.022%)
<ul>
<li>E210: Primary hyperparathyroidism (0.0032%)</li>
<li>E211: Secondary hyperparathyroidism, not elsewhere classified (0.00059%)</li>
<li>E212: Other hyperparathyroidism (0.0003%)</li>
<li>E213: Hyperparathyroidism, unspecified (0.017%)</li>
<li>E215: Disorder of parathyroid gland, unspecified (0.0012%)</li>
</ul></li>
<li>E22: Hyperfunction of pituitary gland (0.02%)
<ul>
<li>E220: Acromegaly and pituitary gigantism (0.0041%)</li>
<li>E222: Syndrome of inappropriate secretion of antidiuretic hormone (0.016%)</li>
</ul></li>
<li>E23: Hypofunction and other disorders of the pituitary gland (0.037%)
<ul>
<li>E230: Hypopituitarism (0.016%)</li>
<li>E232: Diabetes insipidus (0.016%)</li>
<li>E233: Hypothalamic dysfunction, not elsewhere classified (0.00059%)</li>
<li>E236: Other disorders of pituitary gland (0.00089%)</li>
<li>E237: Disorder of pituitary gland, unspecified (0.0032%)</li>
</ul></li>
<li>E24: Cushing’s syndrome (0.008%)
<ul>
<li>E240: Pituitary-dependent Cushing’s disease (0.0003%)</li>
<li>E242: Drug-induced Cushing’s syndrome (0.0012%)</li>
<li>E249: Cushing’s syndrome, unspecified (0.0065%)</li>
</ul></li>
<li>E25: Adrenogenital disorders (0.0018%)
<ul>
<li>E250: 1 Congenital adrenogenital disorders assoc w enzyme deficiency Congenital adrenogenital disorders associated with enzyme deficiency (0.0018%)</li>
</ul></li>
<li>E26: Hyperaldosteronism (0.0012%)
<ul>
<li>E268: Other hyperaldosteronism (0.00059%)</li>
<li>E269: Hyperaldosteronism, unspecified (0.00059%)</li>
</ul></li>
<li>E27: Other disorders of adrenal gland (0.071%)
<ul>
<li>E271: Primary adrenocortical insufficiency (0.027%)</li>
<li>E272: Addisonian crisis (0.003%)</li>
<li>E273: Drug-induced adrenocortical insufficiency (0.0003%)</li>
<li>E274: Other and unspecified adrenocortical insufficiency (0.035%)</li>
<li>E278: Other specified disorders of adrenal gland (0.00089%)</li>
<li>E279: Disorder of adrenal gland, unspecified (0.0047%)</li>
</ul></li>
<li>E28: Ovarian dysfunction (0.00089%)
<ul>
<li>E282: Polycystic ovarian syndrome (0.00059%)</li>
<li>E283: Primary ovarian failure (0.0003%)</li>
</ul></li>
<li>E29: Testicular dysfunction (0.00089%)
<ul>
<li>E291: Testicular hypofunction (0.00089%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
E3 (0.023%)
</summary>
<ul>
<li>E31: Polyglandular dysfunction (0.0015%)
<ul>
<li>E310: Autoimmune polyglandular failure (0.0015%)</li>
</ul></li>
<li>E34: Other endocrine disorders (0.021%)
<ul>
<li>E340: Carcinoid syndrome (0.015%)</li>
<li>E343: Short stature due to endocrine disorder (0.0018%)</li>
<li>E348: Other specified endocrine disorders (0.0024%)</li>
<li>E349: Endocrine disorder, unspecified (0.0024%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
<strong>E66: Overweight and obesity (2%)</strong>
</summary>
<ul>
<li>E660: Obesity due to excess calories (0.0053%)</li>
<li>E661: Drug-induced obesity (0.0003%)</li>
<li>E662: Morbid (severe) obesity with alveolar hypoventilation (0.04%)</li>
<li><strong>E668: Other obesity (1.2%)</strong></li>
<li>E669: Obesity, unspecified (0.8%)</li>
</ul>
</details></li>
<li><details>
<summary>
E67: Other hyperalimentation (0.00059%)
</summary>
<ul>
<li>E671: Hypercarotinemia (0.0003%)</li>
<li>E678: Other specified hyperalimentation (0.0003%)</li>
</ul>
</details></li>
<li>E68: Sequelae of hyperalimentation (0.0003%)</li>
<li><details>
<summary>
<strong>E7 (3.5%)</strong>
</summary>
<ul>
<li>E70: Disorders of aromatic amino-acid metabolism (0.0035%)
<ul>
<li>E701: Other hyperphenylalaninemias (0.0021%)</li>
<li>E702: Disorders of tyrosine metabolism (0.00089%)</li>
<li>E703: Albinism (0.00059%)</li>
</ul></li>
<li>E71: 0 Disord of branched-chain amino-acid metab &amp; fatty-acid metab Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism (0.018%)
<ul>
<li>E710: Maple-syrup-urine disease (0.00059%)</li>
<li>E711: Other disorders of branched-chain amino-acid metabolism (0.0035%)</li>
<li>E713: Disorders of fatty-acid metabolism (0.014%)</li>
</ul></li>
<li>E72: Other disorders of amino-acid metabolism (0.037%)
<ul>
<li>E720: Disorders of amino-acid transport (0.00089%)</li>
<li>E721: Disorders of sulfur-bearing amino-acid metabolism (0.0021%)</li>
<li>E722: Disorders of urea cycle metabolism (0.027%)</li>
<li>E723: Disorders of lysine and hydroxylysine metabolism (0.0018%)</li>
<li>E724: Disorders of ornithine metabolism (0.00089%)</li>
<li>E725: Disorders of glycine metabolism (0.0041%)</li>
<li>E729: Disorder of amino-acid metabolism, unspecified (0.00059%)</li>
</ul></li>
<li>E73: Lactose intolerance (0.0003%)
<ul>
<li>E730: Congenital lactase deficiency (0.0003%)</li>
</ul></li>
<li>E74: Other disorders of carbohydrate metabolism (0.019%)
<ul>
<li>E740: Glycogen storage disease (0.0077%)</li>
<li>E742: Disorders of galactose metabolism (0.0003%)</li>
<li>E743: Other disorders of intestinal carbohydrate absorption (0.0038%)</li>
<li>E744: Disorders of pyruvate metabolism and gluconeogenesis (0.0044%)</li>
<li>E748: Other specified disorders of carbohydrate metabolism (0.0024%)</li>
<li>E749: Disorder of carbohydrate metabolism, unspecified (0.0003%)</li>
</ul></li>
<li>E75: 0 Disord of sphingolipid metab and oth lipid storage disorders Disorders of sphingolipid metabolism and other lipid storage disorders (0.063%)
<ul>
<li>E750: GM2 gangliosidosis (0.0053%)</li>
<li>E751: Other and unspecified gangliosidosis (0.0038%)</li>
<li>E752: Other sphingolipidosis (0.037%)</li>
<li>E754: Neuronal ceroid lipofuscinosis (0.017%)</li>
<li>E755: Other lipid storage disorders (0.0003%)</li>
<li>E756: Lipid storage disorder, unspecified (0.00059%)</li>
</ul></li>
<li>E76: Disorders of glycosaminoglycan metabolism (0.017%)
<ul>
<li>E760: Mucopolysaccharidosis, type I (0.003%)</li>
<li>E761: Mucopolysaccharidosis, type II (0.0041%)</li>
<li>E762: Other mucopolysaccharidoses (0.0053%)</li>
<li>E763: Mucopolysaccharidosis, unspecified (0.0047%)</li>
</ul></li>
<li>E77: Disorders of glycoprotein metabolism (0.0065%)
<ul>
<li>E770: Defects in post-translational modification of lysosomal enzymes (0.0018%)</li>
<li>E771: Defects in glycoprotein degradation (0.00059%)</li>
<li>E778: Other disorders of glycoprotein metabolism (0.0041%)</li>
</ul></li>
<li><strong>E78: Disorders of lipoprotein metabolism and other lipidemias (3.3%)</strong>
<ul>
<li>E780: Pure hypercholesterolemia (0.52%)</li>
<li>E781: Pure hyperglyceridemia (0.014%)</li>
<li>E782: Mixed hyperlipidemia (0.023%)</li>
<li>E784: Other hyperlipidemia (0.00059%)</li>
<li><strong>E785: Hyperlipidemia, unspecified (2.7%)</strong></li>
<li>E786: Lipoprotein deficiency (0.0083%)</li>
<li>E789: Disorder of lipoprotein metabolism, unspecified (0.0083%)</li>
</ul></li>
<li>E79: Disorders of purine and pyrimidine metabolism (0.0021%)
<ul>
<li>E790: 1 Hyperuricemia w/o signs of inflam arthrit and tophaceous dis Hyperuricemia without signs of inflammatory arthritis and tophaceous disease (0.00059%)</li>
<li>E791: Lesch-Nyhan syndrome (0.0012%)</li>
<li>E798: Other disorders of purine and pyrimidine metabolism (0.0003%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
<strong>E8 (3.1%)</strong>
</summary>
<ul>
<li>E80: Disorders of porphyrin and bilirubin metabolism (0.0044%)
<ul>
<li>E800: Hereditary erythropoietic porphyria (0.00059%)</li>
<li>E801: Porphyria cutanea tarda (0.0003%)</li>
<li>E802: Other and unspecified porphyria (0.0021%)</li>
<li>E803: Defects of catalase and peroxidase (0.0003%)</li>
<li>E804: Gilbert syndrome (0.0003%)</li>
<li>E805: Crigler-Najjar syndrome (0.00089%)</li>
</ul></li>
<li>E83: Disorders of mineral metabolism (0.15%)
<ul>
<li>E830: Disorders of copper metabolism (0.0083%)</li>
<li>E831: Disorders of iron metabolism (0.06%)</li>
<li>E833: Disorders of phosphorus metabolism and phosphatases (0.0021%)</li>
<li>E834: Disorders of magnesium metabolism (0.0038%)</li>
<li>E835: Disorders of calcium metabolism (0.08%)</li>
</ul></li>
<li>E84: Cystic fibrosis (0.15%)
<ul>
<li>E840: Cystic fibrosis with pulmonary manifestations (0.036%)</li>
<li>E841: Cystic fibrosis with intestinal manifestations (0.0015%)</li>
<li>E848: Cystic fibrosis with other manifestations (0.074%)</li>
<li>E849: Cystic fibrosis, unspecified (0.043%)</li>
</ul></li>
<li>E85: Amyloidosis (0.4%)
<ul>
<li>E850: Non-neuropathic heredofamilial amyloidosis (0.0015%)</li>
<li>E851: Neuropathic heredofamilial amyloidosis (0.0018%)</li>
<li>E852: Heredofamilial amyloidosis, unspecified (0.0027%)</li>
<li>E853: Secondary systemic amyloidosis (0.0003%)</li>
<li>E854: Organ-limited amyloidosis (0.22%)</li>
<li>E858: Other amyloidosis (0.0032%)</li>
<li>E859: Amyloidosis, unspecified (0.17%)</li>
</ul></li>
<li>E86: Volume depletion (0.49%)</li>
<li><strong>E87: Other disorders of fluid, electrolyte and acid-base balance (1.4%)</strong>
<ul>
<li>E870: Hyperosmolality and hypernatremia (0.2%)</li>
<li>E871: Hypo-osmolality and hyponatremia (0.12%)</li>
<li>E872: Acidosis (0.59%)</li>
<li>E873: Alkalosis (0.0018%)</li>
<li>E875: Hyperkalemia (0.22%)</li>
<li>E876: Hypokalemia (0.052%)</li>
<li>E877: Fluid overload (0.073%)</li>
<li>E878: Other disorders of electrolyte and fluid balance, not elsewhere classified (0.12%)</li>
</ul></li>
<li>E88: Other and unspecified metabolic disorders (0.53%)
<ul>
<li>E880: Disorders of plasma-protein metabolism, not elsewhere classified (0.073%)</li>
<li>E881: Lipodystrophy, not elsewhere classified (0.00059%)</li>
<li>E882: Lipomatosis, not elsewhere classified (0.0003%)</li>
<li>E883: Tumor lysis syndrome (0.0077%)</li>
<li>E888: Other specified metabolic disorders (0.005%)</li>
<li>E889: Metabolic disorder, unspecified (0.44%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
A03: Shigellosis (0.00089%)
</summary>
<ul>
<li>A039: Shigellosis, unspecified (0.00089%)</li>
</ul>
</details></li>
<li><details>
<summary>
<strong>A04: Other bacterial intestinal infections (2.1%)</strong>
</summary>
<ul>
<li>A044: Other intestinal Escherichia coli infections (0.00089%)</li>
<li>A045: Campylobacter enteritis (0.00059%)</li>
<li>A046: Enteritis due to Yersinia enterocolitica (0.0003%)</li>
<li><strong>A047: Enterocolitis due to Clostridium difficile (2.1%)</strong></li>
<li>A048: Other specified bacterial intestinal infections (0.024%)</li>
<li>A049: Bacterial intestinal infection, unspecified (0.0059%)</li>
</ul>
</details></li>
<li><details>
<summary>
A05: Other bacterial foodborne intoxications, not elsewhere classified (0.0012%)
</summary>
<ul>
<li>A051: Botulism food poisoning (0.00059%)</li>
<li>A059: Bacterial foodborne intoxication, unspecified (0.00059%)</li>
</ul>
</details></li>
<li><details>
<summary>
A06: Amebiasis (0.0015%)
</summary>
<ul>
<li>A064: Amebic liver abscess (0.00059%)</li>
<li>A066: Amebic brain abscess (0.00089%)</li>
</ul>
</details></li>
<li><details>
<summary>
A07: Other protozoal intestinal diseases (0.00089%)
</summary>
<ul>
<li>A071: Giardiasis [lambliasis] (0.0003%)</li>
<li>A072: Cryptosporidiosis (0.0003%)</li>
<li>A073: Isosporiasis (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
A08: Viral and other specified intestinal infections (0.038%)
</summary>
<ul>
<li>A080: Rotaviral enteritis (0.0003%)</li>
<li>A081: 0 Acute gastrent d/t Norwalk agent and oth small round viruses Acute gastroenteropathy due to Norwalk agent and other small round viruses (0.0065%)</li>
<li>A083: Other viral enteritis (0.0012%)</li>
<li>A084: Viral intestinal infection, unspecified (0.03%)</li>
</ul>
</details></li>
<li><details>
<summary>
A09: Infectious gastroenteritis and colitis, unspecified (0.71%)
</summary>
<ul>
<li>A090 (0.14%)</li>
<li>A099 (0.57%)</li>
</ul>
</details></li>
<li><details>
<summary>
A2 (0.0068%)
</summary>
<ul>
<li>A21: Tularemia (0.0003%)
<ul>
<li>A219: Tularemia, unspecified (0.0003%)</li>
</ul></li>
<li>A28: Other zoonotic bacterial diseases, not elsewhere classified (0.0065%)
<ul>
<li>A280: Pasteurellosis (0.0065%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
A31: Infection due to other mycobacteria (0.11%)
</summary>
<ul>
<li>A310: Pulmonary mycobacterial infection (0.094%)</li>
<li>A318: Other mycobacterial infections (0.0012%)</li>
<li>A319: Mycobacterial infection, unspecified (0.014%)</li>
</ul>
</details></li>
<li><details>
<summary>
A32: Listeriosis (0.0097%)
</summary>
<ul>
<li>A321: Listerial meningitis and meningoencephalitis (0.0044%)</li>
<li>A327: Listerial sepsis (0.0041%)</li>
<li>A329: Listeriosis, unspecified (0.0012%)</li>
</ul>
</details></li>
<li>A35: Other tetanus (0.0003%)</li>
<li><details>
<summary>
A39: Meningococcal infection (0.013%)
</summary>
<ul>
<li>A390: Meningococcal meningitis (0.003%)</li>
<li>A391: Waterhouse-Friderichsen syndrome (0.0035%)</li>
<li>A392: Acute meningococcemia (0.0003%)</li>
<li>A394: Meningococcemia, unspecified (0.0056%)</li>
<li>A398: Other meningococcal infections (0.0003%)</li>
<li>A399: Meningococcal infection, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
A42: Actinomycosis (0.0015%)
</summary>
<ul>
<li>A420: Pulmonary actinomycosis (0.0003%)</li>
<li>A427: Actinomycotic sepsis (0.00059%)</li>
<li>A428: Other forms of actinomycosis (0.0003%)</li>
<li>A429: Actinomycosis, unspecified (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
A43: Nocardiosis (0.012%)
</summary>
<ul>
<li>A430: Pulmonary nocardiosis (0.0062%)</li>
<li>A438: Other forms of nocardiosis (0.0018%)</li>
<li>A439: Nocardiosis, unspecified (0.0038%)</li>
</ul>
</details></li>
<li><details>
<summary>
A48: Other bacterial diseases, not elsewhere classified (0.049%)
</summary>
<ul>
<li>A480: Gas gangrene (0.003%)</li>
<li>A481: Legionnaires’ disease (0.04%)</li>
<li>A483: Toxic shock syndrome (0.0035%)</li>
<li>A488: Other specified bacterial diseases (0.0032%)</li>
</ul>
</details></li>
<li><details>
<summary>
A49: Bacterial infection of unspecified site (0.41%)
</summary>
<ul>
<li>A490: Staphylococcal infection, unspecified site (0.14%)</li>
<li>A491: Streptococcal infection, unspecified site (0.054%)</li>
<li>A492: Hemophilus influenzae infection, unspecified site (0.0027%)</li>
<li>A493: Mycoplasma infection, unspecified site (0.0012%)</li>
<li>A498: Other bacterial infections of unspecified site (0.047%)</li>
<li>A499: Bacterial infection, unspecified (0.17%)</li>
</ul>
</details></li>
<li><details>
<summary>
A54: Gonococcal infection (0.0003%)
</summary>
<ul>
<li>A540: Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
A6 (0.0053%)
</summary>
<ul>
<li>A63: Other predominantly sexually transmitted diseases, not elsewhere classified (0.00059%)
<ul>
<li>A630: Anogenital (venereal) warts (0.00059%)</li>
</ul></li>
<li>A64: Unspecified sexually transmitted disease (0.0003%)</li>
<li>A69: Other spirochetal infections (0.0044%)
<ul>
<li>A692: Lyme disease (0.0044%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
A7 (0.0074%)
</summary>
<ul>
<li>A74: Other diseases caused by chlamydiae (0.0003%)
<ul>
<li>A749: Chlamydial infection, unspecified (0.0003%)</li>
</ul></li>
<li>A77: Spotted fever [tick-borne rickettsioses] (0.0059%)
<ul>
<li>A770: Spotted fever due to Rickettsia rickettsii (0.0024%)</li>
<li>A778: Other spotted fevers (0.0035%)</li>
</ul></li>
<li>A78: Q fever (0.00089%)</li>
<li>A79: Other rickettsioses (0.0003%)
<ul>
<li>A799: Rickettsiosis, unspecified (0.0003%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
A8 (0.18%)
</summary>
<ul>
<li>A81: Atypical virus infections of central nervous system (0.14%)
<ul>
<li>A810: Creutzfeldt-Jakob disease (0.12%)</li>
<li>A812: Progressive multifocal leukoencephalopathy (0.013%)</li>
<li>A819: Atypical virus infection of central nervous system, unspecified (0.0047%)</li>
</ul></li>
<li>A82: Rabies (0.0003%)
<ul>
<li>A829: Rabies, unspecified (0.0003%)</li>
</ul></li>
<li>A83: Mosquito-borne viral encephalitis (0.00089%)
<ul>
<li>A833: St Louis encephalitis (0.0003%)</li>
<li>A839: Mosquito-borne viral encephalitis, unspecified (0.00059%)</li>
</ul></li>
<li>A85: Other viral encephalitis, not elsewhere classified (0.00059%)
<ul>
<li>A851: Adenoviral encephalitis (0.0003%)</li>
<li>A858: Other specified viral encephalitis (0.0003%)</li>
</ul></li>
<li>A86: Unspecified viral encephalitis (0.028%)</li>
<li>A87: Viral meningitis (0.011%)
<ul>
<li>A870: Enteroviral meningitis (0.0003%)</li>
<li>A872: Lymphocytic choriomeningitis (0.0015%)</li>
<li>A879: Viral meningitis, unspecified (0.0094%)</li>
</ul></li>
<li>A89: Unspecified viral infection of central nervous system (0.003%)</li>
</ul>
</details></li>
<li><details>
<summary>
A9 (0.033%)
</summary>
<ul>
<li>A90: Dengue fever [classical dengue] (0.00059%)</li>
<li>A92: Other mosquito-borne viral fevers (0.031%)
<ul>
<li>A920: Chikungunya virus disease (0.0003%)</li>
<li>A923: West Nile virus infection (0.031%)</li>
</ul></li>
<li>A98: Other viral hemorrhagic fevers, not elsewhere classified (0.0018%)
<ul>
<li>A984: Ebola virus disease (0.00059%)</li>
<li>A985: Hemorrhagic fever with renal syndrome (0.0012%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
L (1.3%)
</summary>
<ul>
<li>L0 (0.69%)
<ul>
<li>L00: Staphylococcal scalded skin syndrome (0.0018%)</li>
<li>L01: Impetigo (0.0003%)
<ul>
<li>L010: Impetigo (0.0003%)</li>
</ul></li>
<li>L02: Cutaneous abscess, furuncle and carbuncle (0.079%)
<ul>
<li>L020: Cutaneous abscess, furuncle and carbuncle of face (0.0021%)</li>
<li>L021: Cutaneous abscess, furuncle and carbuncle of neck (0.0032%)</li>
<li>L022: Cutaneous abscess, furuncle and carbuncle of trunk (0.019%)</li>
<li>L023: Cutaneous abscess, furuncle and carbuncle of buttock (0.0094%)</li>
<li>L024: Cutaneous abscess, furuncle and carbuncle of limb (0.02%)</li>
<li>L028: Cutaneous abscess, furuncle and carbuncle of other sites (0.0024%)</li>
<li>L029: Cutaneous abscess, furuncle and carbuncle, unspecified (0.024%)</li>
</ul></li>
<li>L03: Cellulitis and acute lymphangitis (0.47%)
<ul>
<li>L030: Cellulitis and acute lymphangitis of finger and toe (0.0015%)</li>
<li>L031: Cellulitis and acute lymphangitis of other parts of limb (0.18%)</li>
<li>L032: Cellulitis and acute lymphangitis of face and neck (0.0047%)</li>
<li>L033: Cellulitis and acute lymphangitis of trunk (0.02%)</li>
<li>L038: Cellulitis and acute lymphangitis of other sites (0.0059%)</li>
<li>L039: Cellulitis and acute lymphangitis, unspecified (0.26%)</li>
</ul></li>
<li>L08: Other local infections of skin and subcutaneous tissue (0.14%)
<ul>
<li>L088: Other specified local infections of the skin and subcutaneous tissue (0.00059%)</li>
<li>L089: Local infection of the skin and subcutaneous tissue, unspecified (0.14%)</li>
</ul></li>
</ul></li>
<li>L1 (0.042%)
<ul>
<li>L10: Pemphigus (0.014%)
<ul>
<li>L100: Pemphigus vulgaris (0.005%)</li>
<li>L102: Pemphigus foliaceous (0.0003%)</li>
<li>L108: Other pemphigus (0.0015%)</li>
<li>L109: Pemphigus, unspecified (0.0071%)</li>
</ul></li>
<li>L11: Other acantholytic disorders (0.0003%)
<ul>
<li>L111: Transient acantholytic dermatosis [Grover] (0.0003%)</li>
</ul></li>
<li>L12: Pemphigoid (0.027%)
<ul>
<li>L120: Bullous pemphigoid (0.02%)</li>
<li>L121: Cicatricial pemphigoid (0.0012%)</li>
<li>L123: Acquired epidermolysis bullosa (0.0003%)</li>
<li>L129: Pemphigoid, unspecified (0.005%)</li>
</ul></li>
<li>L13: Other bullous disorders (0.0018%)
<ul>
<li>L131: Subcorneal pustular dermatitis (0.0003%)</li>
<li>L139: Bullous disorder, unspecified (0.0015%)</li>
</ul></li>
</ul></li>
<li>L2 (0.0035%)
<ul>
<li>L23: Allergic contact dermatitis (0.0003%)
<ul>
<li>L237: Allergic contact dermatitis due to plants, except food (0.0003%)</li>
</ul></li>
<li>L25: Unspecified contact dermatitis (0.00059%)
<ul>
<li>L253: Unspecified contact dermatitis due to other chemical products (0.0003%)</li>
<li>L259: Unspecified contact dermatitis, unspecified cause (0.0003%)</li>
</ul></li>
<li>L26: Exfoliative dermatitis (0.0012%)</li>
<li>L27: Dermatitis due to substances taken internally (0.0012%)
<ul>
<li>L270: Generalized skin eruption due to drugs and medicaments taken internally (0.0012%)</li>
</ul></li>
<li>L28: Lichen simplex chronicus and prurigo (0.0003%)
<ul>
<li>L280: Lichen simplex chronicus (0.0003%)</li>
</ul></li>
</ul></li>
<li>L3 (0.0041%)
<ul>
<li>L30: Other and unspecified dermatitis (0.0041%)
<ul>
<li>L303: Infective dermatitis (0.0003%)</li>
<li>L304: Erythema intertrigo (0.0003%)</li>
<li>L309: Dermatitis, unspecified (0.0035%)</li>
</ul></li>
</ul></li>
<li>L4 (0.017%)
<ul>
<li>L40: Psoriasis (0.016%)
<ul>
<li>L401: Generalized pustular psoriasis (0.00089%)</li>
<li>L405: Arthropathic psoriasis (0.0077%)</li>
<li>L408: Other psoriasis (0.0003%)</li>
<li>L409: Psoriasis, unspecified (0.0068%)</li>
</ul></li>
<li>L41: Parapsoriasis (0.0003%)
<ul>
<li>L419: Parapsoriasis, unspecified (0.0003%)</li>
</ul></li>
<li>L43: Lichen planus (0.00089%)
<ul>
<li>L438: Other lichen planus (0.0003%)</li>
<li>L439: Lichen planus, unspecified (0.00059%)</li>
</ul></li>
</ul></li>
<li>L5 (0.036%)
<ul>
<li>L50: Urticaria (0.00059%)
<ul>
<li>L506: Contact urticaria (0.0003%)</li>
<li>L509: Urticaria, unspecified (0.0003%)</li>
</ul></li>
<li>L51: Erythema multiforme (0.03%)
<ul>
<li>L511: Stevens-Johnson syndrome (0.014%)</li>
<li>L512: Toxic epidermal necrolysis [Lyell] (0.014%)</li>
<li>L519: Erythema multiforme, unspecified (0.00059%)</li>
</ul></li>
<li>L53: Other erythematous conditions (0.0053%)
<ul>
<li>L538: Other specified erythematous conditions (0.00089%)</li>
<li>L539: Erythematous condition, unspecified (0.0044%)</li>
</ul></li>
<li>L55: Sunburn (0.0003%)
<ul>
<li>L559: Sunburn, unspecified (0.0003%)</li>
</ul></li>
<li>L57: Skin changes due to chronic exposure to nonionizing radiation (0.0003%)
<ul>
<li>L570: Actinic keratosis (0.0003%)</li>
</ul></li>
</ul></li>
<li>L6 (0.0018%)
<ul>
<li>L60: Nail disorders (0.0015%)
<ul>
<li>L605: Yellow nail syndrome (0.0015%)</li>
</ul></li>
<li>L67: Hair color and hair shaft abnormalities (0.0003%)
<ul>
<li>L678: Other hair color and hair shaft abnormalities (0.0003%)</li>
</ul></li>
</ul></li>
<li>L7 (0.003%)
<ul>
<li>L72: Follicular cysts of skin and subcutaneous tissue (0.00089%)
<ul>
<li>L720: Epidermal cyst (0.00059%)</li>
<li>L721: Pilar and trichodermal cyst (0.0003%)</li>
</ul></li>
<li>L73: Other follicular disorders (0.0021%)
<ul>
<li>L731: Pseudofolliculitis barbae (0.0003%)</li>
<li>L732: Hidradenitis suppurativa (0.0015%)</li>
<li>L739: Follicular disorder, unspecified (0.0003%)</li>
</ul></li>
</ul></li>
<li>L8 (0.32%)
<ul>
<li>L88: Pyoderma gangrenosum (0.0035%)</li>
<li>L89: Pressure ulcer (0.31%)
<ul>
<li>L891: Pressure ulcer of back (0.00089%)</li>
<li>L892: Pressure ulcer of hip (0.0038%)</li>
<li>L893: Pressure ulcer of buttock (0.036%)</li>
<li>L899: Pressure ulcer of unspecified site (0.27%)</li>
</ul></li>
</ul></li>
<li>L9 (0.2%)
<ul>
<li>L90: Atrophic disorders of skin (0.0012%)
<ul>
<li>L905: Scar conditions and fibrosis of skin (0.0012%)</li>
</ul></li>
<li>L92: Granulomatous disorders of skin and subcutaneous tissue (0.0053%)
<ul>
<li>L928: Other granulomatous disorders of the skin and subcutaneous tissue (0.0003%)</li>
<li>L929: Granulomatous disorder of the skin and subcutaneous tissue, unspecified (0.005%)</li>
</ul></li>
<li>L93: Lupus erythematosus (0.049%)
<ul>
<li>L930: Discoid lupus erythematosus (0.048%)</li>
<li>L932: Other local lupus erythematosus (0.0003%)</li>
</ul></li>
<li>L94: Other localized connective tissue disorders (0.00089%)
<ul>
<li>L940: Localized scleroderma [morphea] (0.0003%)</li>
<li>L948: Other specified localized connective tissue disorders (0.0003%)</li>
<li>L949: Localized connective tissue disorder, unspecified (0.0003%)</li>
</ul></li>
<li>L95: Vasculitis limited to skin, not elsewhere classified (0.00089%)
<ul>
<li>L950: Livedoid vasculitis (0.00059%)</li>
<li>L959: Vasculitis limited to the skin, unspecified (0.0003%)</li>
</ul></li>
<li>L97: Non-pressure chronic ulcer of lower limb, not elsewhere classified (0.039%)</li>
<li>L98: Other disorders of skin and subcutaneous tissue, not elsewhere classified (0.1%)
<ul>
<li>L982: Febrile neutrophilic dermatosis [Sweet] (0.0012%)</li>
<li>L983: Eosinophilic cellulitis [Wells] (0.0003%)</li>
<li>L984: 0 Non-pressure chronic ulcer of skin, not elsewhere classified Non-pressure chronic ulcer of skin, not elsewhere classified (0.084%)</li>
<li>L985: Mucinosis of the skin (0.00059%)</li>
<li>L988: Other specified disorders of the skin and subcutaneous tissue (0.0074%)</li>
<li>L989: Disorder of the skin and subcutaneous tissue, unspecified (0.011%)</li>
</ul></li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
D60: Acquired pure red cell aplasia [erythroblastopenia] (0.0065%)
</summary>
<ul>
<li>D609: Acquired pure red cell aplasia, unspecified (0.0065%)</li>
</ul>
</details></li>
<li>D65: Disseminated intravascular coagulation [defibrination syndrome] (0.17%)</li>
<li>D66: Hereditary factor VIII deficiency (0.019%)</li>
<li>D67: Hereditary factor IX deficiency (0.0018%)</li>
<li><details>
<summary>
D68: Other coagulation defects (0.44%)
</summary>
<ul>
<li>D680: Von Willebrand’s disease (0.0047%)</li>
<li>D681: Hereditary factor XI deficiency (0.00059%)</li>
<li>D682: Hereditary deficiency of other clotting factors (0.015%)</li>
<li>D684: Acquired coagulation factor deficiency (0.0038%)</li>
<li>D685: Primary thrombophilia (0.017%)</li>
<li>D686: Other thrombophilia (0.036%)</li>
<li>D688: Other specified coagulation defects (0.0038%)</li>
<li>D689: Coagulation defect, unspecified (0.36%)</li>
</ul>
</details></li>
<li><details>
<summary>
D69: Purpura and other hemorrhagic conditions (0.22%)
</summary>
<ul>
<li>D690: Allergic purpura (0.0021%)</li>
<li>D691: Qualitative platelet defects (0.00089%)</li>
<li>D692: Other nonthrombocytopenic purpura (0.0015%)</li>
<li>D693: Immune thrombocytopenic purpura (0.073%)</li>
<li>D694: Other primary thrombocytopenia (0.011%)</li>
<li>D695: Secondary thrombocytopenia (0.0083%)</li>
<li>D696: Thrombocytopenia, unspecified (0.12%)</li>
<li>D698: Other specified hemorrhagic conditions (0.0003%)</li>
<li>D699: Hemorrhagic condition, unspecified (0.0041%)</li>
</ul>
</details></li>
<li><details>
<summary>
D7 (0.32%)
</summary>
<ul>
<li>D70: Neutropenia (0.12%)</li>
<li>D71: Functional disorders of polymorphonuclear neutrophils (0.0091%)</li>
<li>D72: Other disorders of white blood cells (0.053%)
<ul>
<li>D720: Genetic anomalies of leukocytes (0.0003%)</li>
<li>D721: Eosinophilia (0.0038%)</li>
<li>D728: Other specified disorders of white blood cells (0.048%)</li>
<li>D729: Disorder of white blood cells, unspecified (0.0003%)</li>
</ul></li>
<li>D73: Diseases of spleen (0.033%)
<ul>
<li>D730: Hyposplenism (0.0003%)</li>
<li>D731: Hypersplenism (0.0018%)</li>
<li>D732: Chronic congestive splenomegaly (0.0003%)</li>
<li>D733: Abscess of spleen (0.003%)</li>
<li>D735: Infarction of spleen (0.016%)</li>
<li>D738: Other diseases of spleen (0.0027%)</li>
<li>D739: Disease of spleen, unspecified (0.0086%)</li>
</ul></li>
<li>D74: Methemoglobinemia (0.00089%)
<ul>
<li>D749: Methemoglobinemia, unspecified (0.00089%)</li>
</ul></li>
<li>D75: Other and unspecified diseases of blood and blood-forming organs (0.041%)
<ul>
<li>D751: Secondary polycythemia (0.0021%)</li>
<li>D752 (0.0083%)</li>
<li>D758: Other specified diseases of blood and blood-forming organs (0.012%)</li>
<li>D759: Disease of blood and blood-forming organs, unspecified (0.018%)</li>
</ul></li>
<li>D76: Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue (0.069%)
<ul>
<li>D760 (0.0083%)</li>
<li>D761: Hemophagocytic lymphohistiocytosis (0.047%)</li>
<li>D762: Hemophagocytic syndrome, infection-associated (0.0083%)</li>
<li>D763: Other histiocytosis syndromes (0.0056%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
D8 (0.46%)
</summary>
<ul>
<li>D80: Immunodeficiency with predominantly antibody defects (0.012%)
<ul>
<li>D800: Hereditary hypogammaglobulinemia (0.0015%)</li>
<li>D801: Nonfamilial hypogammaglobulinemia (0.0041%)</li>
<li>D802: Selective deficiency of immunoglobulin A [IgA] (0.0018%)</li>
<li>D803: Selective deficiency of immunoglobulin G [IgG] subclasses (0.0015%)</li>
<li>D805: Immunodeficiency with increased immunoglobulin M [IgM] (0.0003%)</li>
<li>D809: Immunodeficiency with predominantly antibody defects, unspecified (0.0027%)</li>
</ul></li>
<li>D81: Combined immunodeficiencies (0.0062%)
<ul>
<li>D811: 1 Severe combined immunodeficiency w low T- and B-cell numbers Severe combined immunodeficiency [SCID] with low T- and B-cell numbers (0.0003%)</li>
<li>D813: Adenosine deaminase [ADA] deficiency (0.00059%)</li>
<li>D818: Other combined immunodeficiencies (0.0003%)</li>
<li>D819: Combined immunodeficiency, unspecified (0.005%)</li>
</ul></li>
<li>D82: Immunodeficiency associated with other major defects (0.0056%)
<ul>
<li>D820: Wiskott-Aldrich syndrome (0.0015%)</li>
<li>D821: Di George’s syndrome (0.0032%)</li>
<li>D823: Immunodeficiency following hereditary defective response to Epstein-Barr virus (0.0003%)</li>
<li>D824: Hyperimmunoglobulin E [IgE] syndrome (0.00059%)</li>
</ul></li>
<li>D83: Common variable immunodeficiency (0.0094%)
<ul>
<li>D832: Common variable immunodeficiency with autoantibodies to B- or T-cells (0.0003%)</li>
<li>D839: Common variable immunodeficiency, unspecified (0.0091%)</li>
</ul></li>
<li>D84: Other immunodeficiencies (0.044%)
<ul>
<li>D841: Defects in the complement system (0.0038%)</li>
<li>D848: Other specified immunodeficiencies (0.0003%)</li>
<li>D849: Immunodeficiency, unspecified (0.04%)</li>
</ul></li>
<li>D86: Sarcoidosis (0.32%)
<ul>
<li>D860: Sarcoidosis of lung (0.051%)</li>
<li>D861: Sarcoidosis of lymph nodes (0.0003%)</li>
<li>D868: Sarcoidosis of other sites (0.029%)</li>
<li>D869: Sarcoidosis, unspecified (0.24%)</li>
</ul></li>
<li>D89: Other disorders involving the immune mechanism, not elsewhere classified (0.066%)
<ul>
<li>D890: Polyclonal hypergammaglobulinemia (0.00059%)</li>
<li>D891: Cryoglobulinemia (0.0071%)</li>
<li>D892: Hypergammaglobulinemia, unspecified (0.0035%)</li>
<li>D898: Other specified disorders involving the immune mechanism, not elsewhere classified (0.00089%)</li>
<li>D899: Disorder involving the immune mechanism, unspecified (0.054%)</li>
</ul></li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
B0 (0.13%)
</summary>
<ul>
<li>B00: Herpesviral [herpes simplex] infections (0.067%)
<ul>
<li>B001: Herpesviral vesicular dermatitis (0.0003%)</li>
<li>B002: Herpesviral gingivostomatitis and pharyngotonsillitis (0.0003%)</li>
<li>B003: Herpesviral meningitis (0.0015%)</li>
<li>B004: Herpesviral encephalitis (0.038%)</li>
<li>B007: Disseminated herpesviral disease (0.005%)</li>
<li>B008: Other forms of herpesviral infections (0.0035%)</li>
<li>B009: Herpesviral infection, unspecified (0.019%)</li>
</ul></li>
<li>B01: Varicella [chickenpox] (0.0012%)
<ul>
<li>B011: Varicella encephalitis, myelitis and encephalomyelitis (0.00059%)</li>
<li>B012: Varicella pneumonia (0.00059%)</li>
</ul></li>
<li>B02: Zoster [herpes zoster] (0.058%)
<ul>
<li>B020: Zoster encephalitis (0.0086%)</li>
<li>B021: Zoster meningitis (0.00089%)</li>
<li>B022: Zoster with other nervous system involvement (0.0032%)</li>
<li>B023: Zoster ocular disease (0.003%)</li>
<li>B027: Disseminated zoster (0.0056%)</li>
<li>B028: Zoster with other complications (0.00089%)</li>
<li>B029: Zoster without complications (0.036%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
B25: Cytomegaloviral disease (0.032%)
</summary>
<ul>
<li>B250: Cytomegaloviral pneumonitis (0.011%)</li>
<li>B251: Cytomegaloviral hepatitis (0.00059%)</li>
<li>B258: Other cytomegaloviral diseases (0.008%)</li>
<li>B259: Cytomegaloviral disease, unspecified (0.012%)</li>
</ul>
</details></li>
<li><details>
<summary>
B27: Infectious mononucleosis (0.005%)
</summary>
<ul>
<li>B270: Gammaherpesviral mononucleosis (0.0044%)</li>
<li>B279: Infectious mononucleosis, unspecified (0.00059%)</li>
</ul>
</details></li>
<li><details>
<summary>
B3 (0.24%)
</summary>
<ul>
<li>B30: Viral conjunctivitis (0.0003%)
<ul>
<li>B308: Other viral conjunctivitis (0.0003%)</li>
</ul></li>
<li>B33: Other viral diseases, not elsewhere classified (0.019%)
<ul>
<li>B332: Viral carditis (0.015%)</li>
<li>B333: Retrovirus infections, not elsewhere classified (0.00089%)</li>
<li>B334: Hantavirus (cardio)-pulmonary syndrome [HPS] [HCPS] (0.0015%)</li>
<li>B338: Other specified viral diseases (0.0012%)</li>
</ul></li>
<li>B34: Viral infection of unspecified site (0.14%)
<ul>
<li>B340: Adenovirus infection, unspecified (0.0086%)</li>
<li>B341: Enterovirus infection, unspecified (0.0091%)</li>
<li>B342: Coronavirus infection, unspecified (0.003%)</li>
<li>B343: Parvovirus infection, unspecified (0.0027%)</li>
<li>B344: Papovavirus infection, unspecified (0.0003%)</li>
<li>B348: Other viral infections of unspecified site (0.06%)</li>
<li>B349: Viral infection, unspecified (0.056%)</li>
</ul></li>
<li>B36: Other superficial mycoses (0.0003%)
<ul>
<li>B369: Superficial mycosis, unspecified (0.0003%)</li>
</ul></li>
<li>B37: Candidiasis (0.052%)
<ul>
<li>B370: Candidal stomatitis (0.00059%)</li>
<li>B371: Pulmonary candidiasis (0.0041%)</li>
<li>B374: Candidiasis of other urogenital sites (0.0035%)</li>
<li>B375: Candidal meningitis (0.00089%)</li>
<li>B376: Candidal endocarditis (0.00089%)</li>
<li>B377: Candidal sepsis (0.032%)</li>
<li>B378: Candidiasis of other sites (0.0074%)</li>
<li>B379: Candidiasis, unspecified (0.003%)</li>
</ul></li>
<li>B38: Coccidioidomycosis (0.021%)
<ul>
<li>B380: Acute pulmonary coccidioidomycosis (0.0012%)</li>
<li>B381: Chronic pulmonary coccidioidomycosis (0.0003%)</li>
<li>B382: Pulmonary coccidioidomycosis, unspecified (0.008%)</li>
<li>B384: Coccidioidomycosis meningitis (0.0015%)</li>
<li>B387: Disseminated coccidioidomycosis (0.0041%)</li>
<li>B389: Coccidioidomycosis, unspecified (0.0056%)</li>
</ul></li>
<li>B39: Histoplasmosis (0.011%)
<ul>
<li>B392: Pulmonary histoplasmosis capsulati, unspecified (0.003%)</li>
<li>B399: Histoplasmosis, unspecified (0.0077%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
B4 (0.2%)
</summary>
<ul>
<li>B40: Blastomycosis (0.0077%)
<ul>
<li>B402: Pulmonary blastomycosis, unspecified (0.0024%)</li>
<li>B407: Disseminated blastomycosis (0.00089%)</li>
<li>B408: Other forms of blastomycosis (0.0003%)</li>
<li>B409: Blastomycosis, unspecified (0.0041%)</li>
</ul></li>
<li>B42: Sporotrichosis (0.0003%)
<ul>
<li>B420: Pulmonary sporotrichosis (0.0003%)</li>
</ul></li>
<li>B43: Chromomycosis and pheomycotic abscess (0.00059%)
<ul>
<li>B431: Pheomycotic brain abscess (0.0003%)</li>
<li>B439: Chromomycosis, unspecified (0.0003%)</li>
</ul></li>
<li>B44: Aspergillosis (0.046%)
<ul>
<li>B440: Invasive pulmonary aspergillosis (0.0027%)</li>
<li>B441: Other pulmonary aspergillosis (0.027%)</li>
<li>B447: Disseminated aspergillosis (0.0027%)</li>
<li>B448: Other forms of aspergillosis (0.00089%)</li>
<li>B449: Aspergillosis, unspecified (0.014%)</li>
</ul></li>
<li>B45: Cryptococcosis (0.031%)
<ul>
<li>B450: Pulmonary cryptococcosis (0.0021%)</li>
<li>B451: Cerebral cryptococcosis (0.019%)</li>
<li>B457: Disseminated cryptococcosis (0.0071%)</li>
<li>B459: Cryptococcosis, unspecified (0.0024%)</li>
</ul></li>
<li>B46: Zygomycosis (0.0097%)
<ul>
<li>B460: Pulmonary mucormycosis (0.00089%)</li>
<li>B461: Rhinocerebral mucormycosis (0.0012%)</li>
<li>B463: Cutaneous mucormycosis (0.0003%)</li>
<li>B465: Mucormycosis, unspecified (0.0071%)</li>
<li>B469: Zygomycosis, unspecified (0.0003%)</li>
</ul></li>
<li>B47: Mycetoma (0.00059%)
<ul>
<li>B479: Mycetoma, unspecified (0.00059%)</li>
</ul></li>
<li>B48: Other mycoses, not elsewhere classified (0.0003%)
<ul>
<li>B488: Other specified mycoses (0.0003%)</li>
</ul></li>
<li>B49: Unspecified mycosis (0.11%)</li>
</ul>
</details></li>
<li><details>
<summary>
B57: Chagas’ disease (0.0012%)
</summary>
<ul>
<li>B572: Chagas’ disease (chronic) with heart involvement (0.00089%)</li>
<li>B573: Chagas’ disease (chronic) with digestive system involvement (0.0003%)</li>
</ul>
</details></li>
<li><details>
<summary>
B58: Toxoplasmosis (0.0021%)
</summary>
<ul>
<li>B588: Toxoplasmosis with other organ involvement (0.00089%)</li>
<li>B589: Toxoplasmosis, unspecified (0.0012%)</li>
</ul>
</details></li>
<li>B59: Pneumocystosis (0.045%)</li>
<li><details>
<summary>
B6 (0.0056%)
</summary>
<ul>
<li>B60: Other protozoal diseases, not elsewhere classified (0.0027%)
<ul>
<li>B600: Babesiosis (0.0024%)</li>
<li>B602: Naegleriasis (0.0003%)</li>
</ul></li>
<li>B66: Other fluke infections (0.0003%)
<ul>
<li>B664: Paragonimiasis (0.0003%)</li>
</ul></li>
<li>B67: Echinococcosis (0.00089%)
<ul>
<li>B678: Echinococcosis, unspecified, of liver (0.0003%)</li>
<li>B679: Echinococcosis, other and unspecified (0.00059%)</li>
</ul></li>
<li>B69: Cysticercosis (0.0018%)
<ul>
<li>B690: Cysticercosis of central nervous system (0.0018%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
B7 (0.0018%)
</summary>
<ul>
<li>B76: Hookworm diseases (0.0003%)
<ul>
<li>B769: Hookworm disease, unspecified (0.0003%)</li>
</ul></li>
<li>B78: Strongyloidiasis (0.0015%)
<ul>
<li>B787: Disseminated strongyloidiasis (0.0012%)</li>
<li>B789: Strongyloidiasis, unspecified (0.0003%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
B8 (0.0018%)
</summary>
<ul>
<li>B81: Other intestinal helminthiases, not elsewhere classified (0.0003%)
<ul>
<li>B812: Trichostrongyliasis (0.0003%)</li>
</ul></li>
<li>B83: Other helminthiases (0.0003%)
<ul>
<li>B832: Angiostrongyliasis due to Parastrongylus cantonensis (0.0003%)</li>
</ul></li>
<li>B86: Scabies (0.00059%)</li>
<li>B87: Myiasis (0.0003%)
<ul>
<li>B879: Myiasis, unspecified (0.0003%)</li>
</ul></li>
<li>B88: Other infestations (0.0003%)
<ul>
<li>B889: Infestation, unspecified (0.0003%)</li>
</ul></li>
</ul>
</details></li>
<li><details>
<summary>
B9 (0.35%)
</summary>
<ul>
<li>B90: Sequelae of tuberculosis (0.0065%)
<ul>
<li>B902: Sequelae of tuberculosis of bones and joints (0.0003%)</li>
<li>B909: Sequelae of respiratory and unspecified tuberculosis (0.0062%)</li>
</ul></li>
<li>B91: Sequelae of poliomyelitis (0.047%)</li>
<li>B94: 0 Sequelae of other and unsp infectious and parasitic diseases Sequelae of other and unspecified infectious and parasitic diseases (0.22%)
<ul>
<li>B941: Sequelae of viral encephalitis (0.0035%)</li>
<li>B942: Sequelae of viral hepatitis (0.0015%)</li>
<li>B948: Sequelae of other specified infectious and parasitic diseases (0.21%)</li>
<li>B949: Sequelae of unspecified infectious and parasitic disease (0.0012%)</li>
</ul></li>
<li>B99: Other and unspecified infectious diseases (0.08%)</li>
</ul>
</details></li>
</ul>
<hr />
<ul>
<li><details>
<summary>
H (0.027%)
</summary>
<ul>
<li>H0 (0.0024%)
<ul>
<li>H05: Disorders of orbit (0.0024%)
<ul>
<li>H050: Acute inflammation of orbit (0.0015%)</li>
<li>H059: Unspecified disorder of orbit (0.00089%)</li>
</ul></li>
</ul></li>
<li>H1 (0.0003%)
<ul>
<li>H10: Conjunctivitis (0.0003%)
<ul>
<li>H109: Unspecified conjunctivitis (0.0003%)</li>
</ul></li>
</ul></li>
<li>H3 (0.0003%)
<ul>
<li>H35: Other retinal disorders (0.0003%)
<ul>
<li>H355: Hereditary retinal dystrophy (0.0003%)</li>
</ul></li>
</ul></li>
<li>H4 (0.005%)
<ul>
<li>H40: Glaucoma (0.0015%)
<ul>
<li>H409: Unspecified glaucoma (0.0015%)</li>
</ul></li>
<li>H44: Disorders of globe (0.0012%)
<ul>
<li>H440: Purulent endophthalmitis (0.0012%)</li>
</ul></li>
<li>H47: Other disorders of optic [2nd] nerve and visual pathways (0.0003%)
<ul>
<li>H472: Optic atrophy (0.0003%)</li>
</ul></li>
<li>H49: Paralytic strabismus (0.0021%)
<ul>
<li>H494: Progressive external ophthalmoplegia (0.00059%)</li>
<li>H498: Other paralytic strabismus (0.0012%)</li>
<li>H499: Unspecified paralytic strabismus (0.0003%)</li>
</ul></li>
</ul></li>
<li>H5 (0.0021%)
<ul>
<li>H52: Disorders of refraction and accommodation (0.00059%)
<ul>
<li>H520: Hypermetropia (0.0003%)</li>
<li>H521: Myopia (0.0003%)</li>
</ul></li>
<li>H54: Blindness and low vision (0.0015%)
<ul>
<li>H540: Blindness, both eyes (0.0015%)</li>
</ul></li>
</ul></li>
<li>H6 (0.0083%)
<ul>
<li>H60: Otitis externa (0.0021%)
<ul>
<li>H601: Cellulitis of external ear (0.0003%)</li>
<li>H602: Malignant otitis externa (0.00089%)</li>
<li>H604: Cholesteatoma of external ear (0.0003%)</li>
<li>H609: Unspecified otitis externa (0.00059%)</li>
</ul></li>
<li>H66: Suppurative and unspecified otitis media (0.0062%)
<ul>
<li>H660: Acute suppurative otitis media (0.0003%)</li>
<li>H664: Suppurative otitis media, unspecified (0.0003%)</li>
<li>H669: Otitis media, unspecified (0.0056%)</li>
</ul></li>
</ul></li>
<li>H7 (0.0068%)
<ul>
<li>H70: Mastoiditis and related conditions (0.0059%)
<ul>
<li>H700: Acute mastoiditis (0.00059%)</li>
<li>H701: Chronic mastoiditis (0.0003%)</li>
<li>H709: Unspecified mastoiditis (0.005%)</li>
</ul></li>
<li>H71: Cholesteatoma of middle ear (0.00059%)</li>
<li>H74: Other disorders of middle ear mastoid (0.0003%)
<ul>
<li>H741: Adhesive middle ear disease (0.0003%)</li>
</ul></li>
</ul></li>
<li>H9 (0.0015%)
<ul>
<li>H91: Other and unspecified hearing loss (0.00089%)
<ul>
<li>H913: Deaf nonspeaking, not elsewhere classified (0.0003%)</li>
<li>H919: Unspecified hearing loss (0.00059%)</li>
</ul></li>
<li>H93: Other disorders of ear, not elsewhere classified (0.00059%)
<ul>
<li>H931: Tinnitus (0.00059%)</li>
</ul></li>
</ul></li>
</ul>
</details></li>
</ul>
<p>Source: <span class="citation">Xu et al. (<a href="#ref-CDCreport" role="doc-biblioref">2016</a>)</span>, <span class="citation">(“ICD Order Files 2014,” <a href="#ref-ICDcodes" role="doc-biblioref">n.d.</a>)</span></p>
</div>
<div id="references" class="section level2 unnumbered">
<h2 class="unnumbered">References</h2>
<div id="refs" class="references hanging-indent">
<div id="ref-ICDcodes">
<p>“ICD Order Files 2014.” n.d. <a href="https://www.cdc.gov/nchs/icd/icd10cm.htm">https://www.cdc.gov/nchs/icd/icd10cm.htm</a>.</p>
</div>
<div id="ref-CDCreport">
<p>Xu, Jiaquan, Kenneth D Kochanek, Sherry L Murphy, and Betzaida Tejada-Vera. 2016. “Deaths: Final Data for 2014.” <em>National Vital Statistics Reports</em> 65 (4).</p>
</div>
</div>
</div>
</body>
</html>
